美國

證券交易委員會

華盛頓，特區。20549

時間表 14A

代理人 根據第14(a)條規定提交的聲明

這 1934 年《證券交易法》

由註冊人☒提交

由註冊人以外的當事人提交☐

FOXO TECHNOLOGIES INC.

729 N. Washington Ave.，Suite 600

明尼阿波利斯，MN 55401

致FOXO TECHNOLOGIES INC.股東：

很榮幸邀請您參加2024年股東特別會議（“特別會議”），將於2024年[*] [*].m.（中部時間）在[*]召開。特別會議的正式會議通知和委任書已附上。

特別會議將是股東完全虛擬會議，將通過現場網絡廣播進行。 您可以在線參加特別會議，在特別會議期間訪問 www.[*] 進行投票並提問。

我們很高興利用虛擬股東大會技術爲我們的股東和公司提供便利的訪問和成本節約。虛擬會議格式允許來自世界上任何地方的代表參加。

即使您計劃在線參加特別會議，也請即時通過互聯網、電話或者如果您通過郵件收到打印的委託書，則填寫、簽名並寄回所附委託書以便您的股份得以在特別會議上得到代表。有關表決您股份的說明在您收到的特別會議委託材料中。即使您計劃在線參加特別會議，強烈建議您在特別會議日期前完成並寄回您的委託卡，以確保您的股份在特別會議上得到代表如果您無法出席。股東記錄的互聯網投票設施將全天24小時開放，並將於東部時間 [*], 2024年晚上11:59 關閉。如果您在網上參加特別會議並希望在特別會議上進行表決，即使您事先已寄回您的委託卡，也能實現。

謹代表我們的董事會，感謝您的持續支持和關注。

729 N. Washington Ave.，Suite 600

明尼阿波利斯，MN 55401

2024年股東特別會議通知

於[*]年[*]月[*]日舉行

致FOXO TECHNOLOGIES INC.股東：

特此通知，福克斯科技公司及其子公司（以下簡稱「本公司」）的2024年股東特別會議即將召開。特別會議”）的福克斯科技公司，一家總部設在特拉華州的公司及其子公司。公司,” “根據財務報表基本審計準則對 未經審計的連續財務報表進行審計時，本公 司於2023年12月31日確定了與俱樂部成立憑證 有關的錯誤。”, “我們的,” “我們”或“我們”), will be held as a 「virtual meeting」 via live audio webcast on [*], 2024, at [*] [*].m., Central Time, for the following purposes, as more fully described in the accompanying proxy statement (the “BLAC股東會議”):

1. 批准並通過修訂我們的第三份修正和重新制訂的公司章程的提案（“公司章程”），在2025年9月30日之前的任何時間，以區間爲從一比五（1:5）到一比一百（1:100）的比例進行逆向股票拆分（“A類普通股”）具體比例將在該範圍內由公司的董事會全權決定（“反向拆分”董事會在提交修訂公司章程以實施擬議的股票合併之前，未經股東進一步批准或授權。

2. 爲了遵守紐約證券交易所美國規則713，批准發行等於或超過我們在此發行之前即時流通的A類普通股數量的A類普通股，與 交易所協議（“Smithline Exchange Agreement”與Smithline Family Trust II（“Smithline”);

3. 批准，以便遵守紐交所美國規則713，發行等額或超過我們之前即將發行的A類普通股20%的數量，與 Strata 購買協議自2023年10月13日與ClearThink Capital Partners, LLC簽訂，(“清晰思考”)，由補充的Strata購買協議補充，日期爲2023年10月13日，以及經修改的，與ClearThink Capital Partners, LLC簽署的（“Strata購買協議”），ClearThink同意購買高達500萬美元的我們的A類普通股，並與 中介費協議，日期爲2023年10月9日，經修改 (the “中介協議”), with J.H. Darbie & Co., Inc., a registered broker-dealer (the “查找器”);

4. 爲了遵守紐約證券交易所美國規則713號，批准發行等於或超過我們發行前20%的A類普通股數量與相關發行同時發行的A類普通股數。 證券 購買協議（“SPA”）與機構投資者（“買方”） 根據該協議，公司同意發行給買方和之後也將成爲SPA的簽署方的其他買家（買方，以及其他買家，合稱“購買者”）總額高達2,800,000美元（每個爲“單張債券”或者一起使用 “票據 ”);

5. 如果必要或適當，批准延期特別會議，以徵求支持前述提案的額外委託投票，如果支持前述提案的票數不足；和

6. 其他適當提出的事項，可能出現在特別會議上，或其合法休會或延期中。

根據我們修訂和重新制定的公司章程（“規則”），我們的董事會已經確定2024年[*]爲業務結束日期，作爲記錄 日期（“股權登記日”），確定股東有資格收到通知並出席股東大會及 任何對該大會的延期或推遲。只有在該日期持有公司普通股的記錄持有人有權使 他們的投票在股東大會或任何對該大會的延期或推遲中得以計算。

我們的特別會議將是股東的「虛擬會議」，將通過在線直播音頻網絡獨家進行。

您可以通過訪問FOXO的虛擬會議網站www.[*]在[*]年[*]月[*]日中部時間[*]點參加特別會議的現場音頻網絡直播。當您訪問會議網站時，您將被提示輸入您在收到特別會議通知上提供的16位控制號碼。這個獨特的控制號碼能夠讓我們識別您爲股東，並使您能夠安全地登錄、投票和在會議網站上提交問題。有關如何通過互聯網參加和參與特別會議的進一步說明，包括如何證明持有股票的方法，請訪問www.[*]。

您的投票非常重要。無論您是否以虛擬方式參加特別會議，都非常重要，您的股份要得到代表。您可以通過電話或互聯網投票，或者如果您收到了郵寄的紙質代理卡，則可以填寫並寄回給您的代理卡。投票說明已在附上的代理卡中提供，並在隨附的代理聲明中包含。即使您已通過代理投票，如果您出席特別會議，仍可以親自投票。如果您虛擬參加特別會議，即使之前已提交了您的投票，也可以在當時投票。即使您計劃參加特別會議，我們建議您儘快通過互聯網、電話或郵寄方式投票，方法如代理聲明中描述。

有關2024年7月8日股東會議委託材料的重要通知

2024年[*]月舉行特別股東大會：公司的委託材料

正在WWW.[*].COm上提供

目錄

代理聲明

對於

2024 股東特別會議

[*], 2024

董事會委託您作爲FOXO Technologies Inc.（以下簡稱「FOXO」）的代理人公司,” “根據財務報表基本審計準則對 未經審計的連續財務報表進行審計時，本公 司於2023年12月31日確定了與俱樂部成立憑證 有關的錯誤。”, “我們的,” “我們「」或「」我們）參加我們2024年股東大會（以下簡稱「大會」）在特別會議上，我們公司的股東對2項提案進行了投票。特別會議開始時，代理人出席了21,403,417股A類普通股（以下簡稱「A類股票」），佔據A類普通股的60.77%的流通股和表決權，並出席了23,111,340股B類普通股（以下簡稱「B類股票」），佔據B類普通股的100%的流通股和表決權。因此，持有表決權的一大部分股權在會議上進行了投票，並且我們已經達到了業務交易的法定齊全性。將於[*]年[*]月[*]日，中部時間[*]點舉行董事會特別會議。我們的特別會議將是一場「虛擬會議」， 將完全在線進行，通過現場音頻網絡廣播。公司的主要執行辦公室位於明尼阿波利斯55401號N. Washington Ave. 729號，電話號碼爲(612) 800 0059。

在特別會議上，您將被要求考慮並投票表決以下事項：

1. 批准並通過修訂我們的第三份修正和重新制訂的公司章程的提案（“公司章程”），在2025年9月30日之前的任何時間，以區間爲從一比五（1:5）到一比一百（1:100）的比例進行逆向股票拆分（“A類普通股”）具體比例將在該範圍內由公司的董事會全權決定（“反向拆分”董事會在提交修訂公司章程以實施擬議的股票合併之前，未經股東進一步批准或授權。

2. 爲了遵守紐約證券交易所美國規則713，批准發行等於或超過我們在此發行之前即時流通的A類普通股數量的A類普通股，與 交易所協議（“Smithline Exchange Agreement”與Smithline Family Trust II（“Smithline”);

3. 批准，以便遵守紐交所美國規則713，發行等額或超過我們之前即將發行的A類普通股20%的數量，與 Strata 購買協議自2023年10月13日與ClearThink Capital Partners, LLC簽訂，(“清晰思考“），並於2023年10月13日與ClearThink Capital Partners，LLC簽署的補充條款購買備忘錄補充協議（以下簡稱“Strata購買協議”），ClearThink同意購買我們的A類普通股高達500萬美元，並與 查找費協議，於2023年10月9日修訂的（以下簡稱“中介協議”), with J.H. Darbie & Co., Inc., a registered broker-dealer (the “查找器”);

4. 爲了遵守紐約證券交易所美國規則713號，批准發行等於或超過我們發行前20%的A類普通股數量與相關發行同時發行的A類普通股數。 證券 購買協議（“SPA”）與機構投資者（“買方”） 根據該協議，公司同意發行給買方和之後也將成爲SPA的簽署方的其他買家（買方，以及其他買家，合稱“購買者”）總額高達2,800,000美元（每個爲“單張債券”或者一起使用 “票據 ”);

5. 如果必要或適當，批准延期特別會議，以徵求支持前述提案的額外委託投票，如果支持前述提案的票數不足；和

6. 其他適當提出的事項，可能出現在特別會議上，或其合法休會或延期中。

根據我們修訂和重新制定的公司章程（“規則”），我們的董事會已經確定2024年[*]爲業務結束日期，作爲記錄 日期（“股權登記日用於確定有權收到通知並參加特別會議或任何相關延期或推遲的股東。我們的A類普通股持有人有權在特別會議上投票。我們的特別會議將是股東的「虛擬會議」，將完全在線通過現場音頻網絡廣播進行。

您將能夠通過訪問我們的虛擬會議網站www.[*]於2024年[*][*]日（美國中部時間）上午[*]時，在現場音頻網絡廣播方式參加特別會議。訪問會議網站時，您將被提示輸入在特別會議通知書上提供給您的16位控制編碼。這個獨特的控制編碼可以讓我們識別您爲股東，並使您能夠安全登錄、投票和在會議網站上提交問題。

有關如何通過互聯網參加和參與特別會議的進一步說明，包括如何證明股票所有權的方法，請訪問www.[*]。

本委託書材料和隨附材料是董事會爲年度股東大會而發起委託書的事務。這些材料簡述了您需要知道的信息，以便參與委託或親臨年度股東大會。

我爲什麼會收到這些材料？

董事會邀請您參加特別會議的投票，包括特別會議的任何休會或延期，因爲您在記錄日期結束時是持股人，有權在特別會議上投票。

本委託聲明及隨附材料旨在由董事會代表特別大會拉選票，並總結您在特別大會上代理或親自投票所需了解的信息。

這些材料包括什麼？

這些材料包括本次代理聲明、特別會議通知、代理投票卡以及提交給證券交易委員會的年度10-k表格（“SEC）於2024年6月6日。

特別會議的目的是什麼？

這是公司股東的特別會議。在特別會議上，我們將就以下事項進行投票：

1. 批准並採納一項提案，以在2025年9月30日之前的任何時間內實施股票的反向拆分，拆分比例應在董事會自行決定的區間內確定，在提交擬議的反向拆分章程修正案之前，無需進一步獲得股東的批准或授權。

2. 爲了遵守紐約證券交易所美國規則 713，批准發行與Smithline有關的股票，其數量相當於或超過發行前我公司現有的A類普通股的20% 交易所 更詳細地描述在本代理聲明中;

3. 批准，以便遵守紐交所美國規則713，發行等額或超過我們之前即將發行的A類普通股20%的數量，與 Strata 購買協議， 如本代理聲明中更詳細地描述;

4. 爲了遵守紐交所美國規則713，批准發行A類普通股的股數等於或超過我們發行票據前即時流通的A類普通股的20%。 SPA 與買方簽署的， 如本代理聲明中更詳細描述;

5. 如果必要或適當，批准延期特別會議，以徵求支持前述提案的額外委託投票，如果支持前述提案的票數不足；和

6. 其他適當提出的事項，可能出現在特別會議上，或其合法休會或延期中。

投票委託書是如何運作的？

我們的董事會要求您委任代理。這意味着您授權我們選定的人在特別會議上按照您的指示投票，並在可能出現的任何其他業務上，由他們最好地行事。

誰有投票權？

我們董事會已經確定了[*]年2024年爲業務截止日期，作爲確認股東有權收到特別會議通知並在特別會議上投票的「記錄日」，或任何特別會議的休會或延期。 如果您在記錄日業務結束時持有我們的A類普通股，則可以在特別會議上投票。 在[*]年2024年，A類普通股中有[*]股流通。每股A類普通股均使持有人有權投一票。

股東名冊將列明有權在特別股東大會上投票的記錄股東，可在我們的主要行政辦公室，位於729 N. Washington Ave., Suite 600, Minneapolis, MN 55401進行查閱，查閱期至少爲特別股東大會前10天，並持續至特別股東大會期間。股票轉倉記錄將在股權登記日和特別股東大會日期之間不關閉。

持股人和受益所有人持股有哪些差別（以街頭名稱持有股份）？

如果您在我們的股份轉移機構陸續辦理手續後，把持股股票進行登記，那麼您就是這些股票的「登記持有人」。如果您是登記持有人，公司會把投票材料直接提供給您。

如果您持有的股份存放在券商帳戶、銀行或其他備案持有人名下，那麼您將被視爲這些以「街頭持有人」名義持有的股份的「受益所有人」。如果您的股份以「街頭持有人」名義持有，這些委託材料已經通過該組織轉發給您。作爲受益所有人，您有權指示該組織如何投票您的股份。

誰可以參加特別會議？

持有人和受益所有人可以參加特別會議。如果您的股份以街道名稱持有，並且您希望在特別會議上投票，您需要從銀行、經紀人、提名人、受託人或其他持有您股份的保管人那裏獲得有效的委託書，使您有權在特別會議上投票。

如何進行投票？

如果您在[*] 2024年時直接通過我們的股份轉移代理公司Cont inental Stock Transfer & Trust Company進行登記，那麼您就是登記持有人。登記持有人可以按照以下方式進行投票：通過互聯網、電話或（如果您通過郵寄收到委託卡）郵寄描述的方式。股東還可以參加虛擬會議並進行電子投票。如果您持有通過銀行、經紀人、提名人、受託人或其他保管人持有的股份，請查閱委託卡、通知或其他向您轉發的有關信息，以了解可用的投票選項。

您可以通過[*].com在互聯網上進行表決，按照向您發送的說明進行操作。互聯網表決每天24小時可用，可在2024年[*]11:59 p.m. Eastern Time之前進入。

您可以通過撥打＃-800[*]並按照向您發送的通知或（如果您通過郵寄收到委託卡）向您發送的委託卡進行電話投票。 電話投票每天24小時可用，可在2024年[*]11:59 p.m. Eastern Time之前進入。

● 您可以通過請求、填寫並郵寄紙質代理卡來進行郵寄投票，如通知中所述。您的投票和投票方式不會限制您在決定虛擬參加特別會議時的投票權。

● 如果您希望在特別會議上進行電子投票，請使用您在郵件中收到的唯一控制編號，轉到[*].com。

如果我回復代理卡但沒有做出具體選擇會怎樣？

如果您不是股東，而是通過銀行、經紀人、提名人、受託人或其他託管人持有股份，您必須根據股東的要求向股份的記錄持有人提供投票指示，以便正確投票您的股份。因此，如果您未向您的銀行、經紀人、提名人、受託人或其他託管人提供投票指示，他們可能不會對本次特別會議上提出的任何事項進行投票，您的股份將被視爲「經紀人不投票」，關於這些事項。經紀人不投票將被視爲出席以確定是否有足夠的出席投票來舉行我們的特別會議，但在本代理聲明中的任何提案投票結果上不會產生其他影響。

提案 1（關於修訂公司章程以實施逆向拆分的提案）和5（休會提案）是「例行」事項，您的經紀人可以行使投票裁量權。所有其他提案均被視爲非例行性提案，因此經紀人無法行使自主權來就此類其他提案上的股票進行投票，這些提案將在特別會議上進行討論，如果他們未收到來自客戶的指示，請提交您的投票指示表，以便您的選票得以計入。

我的股票將如何投票？

所有表決權股份，只要在特別會議前填寫、簽署並提交的代理授權書一經接收，且未被撤銷，將按照您在特別會議前提交的代理授權書中的指示進行表決。如果您未指明如何投票，您的代理授權書代表的股份將投票支持每項提案，並針對特別會議可能合理提出的所有其他事項以及與會議進行有關的所有事項進行表決。所有投票將由特別會議指定的選舉檢查員進行統計，選舉檢查員將分別統計肯定和否定的投票，棄權投票以及代理人未行使投票權的情況。

誰爲此委託徵集支付費用？

我們將支付整個徵詢代理的費用，包括估計的[*]美元的費用，以及報銷經費，以便[*]擔任我們的代理徵詢者。除了這些郵寄的代理材料外，我們的董事和僱員也可能以親自、電話或其他通訊方式徵詢代理。董事和僱員不會因徵詢代理而獲得額外的報酬。我們也可能會補償券商、銀行和其他代理人轉發代理材料給受益所有者的費用。

如果我收到多張投票卡或通知怎麼辦？

如果您收到多張投票卡或代理聲明，表示您的股份註冊於不同名稱或不同帳戶。爲確保所有股份投票，請填寫、簽署並遞交每張代理卡或針對每個代理聲明提交一份代理。

如果我與另一位股東共用一個地址怎麼辦？

如果您與另一位股東居住在同一地址，則您和另一位股東居住在同一地址的股東可能會收到一份《委託書》的副本。這個經過SEC批准的流程稱爲「合併」。“然而，如果股東希望在今年或將來在同一地址收到我們的披露文件的多份副本，股東應按照下面描述的說明進行操作。同樣，如果一個地址與另一位股東共用，且兩位股東共同希望僅收到我們的披露文件的一套副本，股東應按照以下說明進行操作：(i)如果股份登記在股東的名下，則股東應聯繫我們，地址爲 729 N. Washington Ave.，Suite 600，Minneapolis，MN 55401，電話爲(612) 800 0059，告知我們該股東的要求；或者(ii)如果股份由銀行、經紀人、提名人、受託人或其他託管人持有，則股東應直接聯繫該銀行、經紀人、提名人、受託人或其他託管人。參與合併的股東將繼續擁有並使用單獨的委託投票說明。Form 10-k的年度報告，Form 10-Q的季度報告，在提交時，該《委託書》以及相關通知也可在[*]上獲得。

我提交委託後可以更改我的投票嗎？

是的。 在特別會議最終投票前，您可以隨時撤銷您的代理權。您可以通過以下三種方式之一撤銷您的代理權：

● 您可以提交另一份日期較晚的適當填寫的代理卡。

● 您可以發送書面通知，說明您正在撤銷您的代理，發送到FOXO Technologies Inc.，729 N. Washington Ave，Suite 600，Minneapolis，MN 55401，Attention：CEO。

● 您可以通過訪問www.[*]並使用您在郵件中收到的唯一控制號碼，通過電子方式參加特別會議並進行投票。僅僅參加會議本身並不能撤銷您的代理。

誰將代表我們的董事會徵求代理？

代理人可能會代表我們的董事會徵集代理，無需額外報酬，公司的董事和員工也可能會親自徵集代理。我們已經聘請[*]爲代理徵求人員。

因信將徵集代理的原始郵件可能會通過電話、電報、傳真、電子郵件和公司董事和員工的個人徵集來補充（這些董事和員工對這些徵集活動不再獲得額外的報酬）。我們還可能通過期刊廣告、我們發出的新聞稿以及在我們的公司網站上張貼的帖子等方式徵集您的代理。 www.foxotechnologies.com除非另有明確規定，否則包含在我們官方網站上的信息不是本委託書的一部分。

投票如何計算？

投票將由特別會議指定的選舉監察員進行統計，該監察員將分別計算“ ,” “AGAINST”和“6. 由公司股東多諾萬·S·羅伊爾提交的提案，關於允許股東按照代理聲明中所述呼叫股東特別會議的事宜。” 票、棄權票和經紀人棄權。棄權票和經紀人棄權將被視爲出席，以確定法定人數。

如果 您的股票由您的銀行或經紀人作爲您的被提名人（即以 「街道名稱」）持有，您需要獲得投票權 來自持有您股票的機構的指示表，並按照該表格中有關如何進行指示的說明進行操作 您的經紀人爲您的股票投票。如果您不向經紀人發出指示，您的經紀人可以按照 「全權委託」 對您的股票進行投票 項目，但不適用於 「非全權委託」 項目。自由裁量項目是根據以下規定被視爲例行提案 紐約證券交易所規則 (”紐約證券交易所”），您的經紀人可以在沒有您的情況下對以街道名義持有的股票進行投票 投票說明。對於您未向經紀人發出指示的非全權委託項目，股票將被視爲經紀商 不投票。根據紐約證券交易所的現行規則，任何董事會成員的選舉，無論是有爭議的還是無爭議的，都被視爲 「非例行的」 因此，不允許經紀人就本次特別會議上的任何提案對你以街道名義持有的股票進行投票，其他 在你沒有指示的情況下，而不是提案1和5。提案 2、3 和 4 是非常規事項，因此如果你持有 通過銀行、經紀商、被提名人、信託機構或其他託管人持有的股票，除非您 向記錄持有者提供投票指示。

每個提案需要多少票才能批准？

投票程序是什麼？

您可以支持或反對每項提案，也可以對每項提案棄權。您應在隨附的委託卡或您的投票指示表上明確您的選擇

所有板塊由代理人代表的份額將根據代理表上指定的選擇進行投票，如果沒有指定選擇，則將根據董事會的建議進行投票。因此，在沒有指定選擇的情況下，代理人將投票。對於 在特別會議上向我們的股東提出的提案。

我的表決是否保密？

是的，您的投票是保密的。有權訪問您的投票的只有選舉檢查人、幫助處理和計算您的投票的人員和出於法律原因需要訪問的人員。有時，股東會在他們的委託卡上提供書面意見，這些意見可能會被轉發給我們公司的管理層和董事會

什麼是法定出席要求？

持有有效會議必須有股東法定人數。 如果代表公司該特別會議有投票權的所有流通股份的至少三分之一出席，無論親自或通過代理，都將出席法定人數。在備案日期，A類普通股總計[*]股流通並有投票權。因此，必須由出席特別會議的股東或代理代表[*]股才能獲得法定人數。

只有在您提交有效的代理投票或在特別會議上投票時，您的股份才會被計入法定人數。棄權和經紀商不投票將計入法定人數要求。

如果我在我的委託卡上標記「棄權」，我的股份將如何表決？

我們將計算一個正確填寫的代理投票卡爲「出席」，以確定是否形成法定人數。棄權，但是該代理投票卡所代表的股份不會對標記了的提案在特別會議上投票贊成或反對。

如何才能查看特別會議的投票結果？

特別會議上將公佈初步投票結果。最終投票結果將在特別會議結束後四個工作日內提交給美國證券交易委員會的8-k表格中公佈。

如果我有其他未被解決的問題怎麼辦？

如果您對我們的特別會議有任何疑問或需要任何幫助，請聯繫我們的代理律師：

[*]

戰略股東顧問兼代理律師

[*]

北美免費電話：

1-[*]

郵箱: [*]

看漲 北美境外集體: +1 [*]

特定受益所有人和管理層的證券所有權

根據2024年10月[*]的情況，以下表格列出了以下內容：(i) 我們熟知的每位持有普通A類股股份超過5%的個人、實體或團體（如1934年《交易法》第13(d)(3)條中所述）的受益所有人；(ii) 我們的每位董事；(iii) 我們的每位具名高管；以及(iv) 所有現任高管和董事作爲一個整體的情況。關於我們主要股東和管理層持有普通股的受益所有權的信息是基於每位使用SEC規則下「受益所有權」概念提供的信息。根據這些規則，如果一個人直接或間接擁有或共享投票權（包括投票或指導投票的權力）或投資權（包括處分或指導處分的權力），則該人被視爲是一種證券的受益所有人。該人還被視爲是對其在此代理聲明日期起60天內有獲得受益所有權的權利的任何證券的受益所有人。根據SEC規則，一個以上的人可能被視爲是同一證券的受益所有人，並且一個人可能被視爲是對其可能沒有任何金錢利益的證券的受益所有人。除下文所述外，每個人對其受益所有權的股份具有獨立的投票和投資權，並且每位股東的地址均爲：FOXO Technologies Inc.，729 N. Washington Ave.，600號套房，明尼阿波利斯，MN 55401。

適用的所有權百分比基於截至2024年10月[*]發行的A類普通股份。

特定的關係和相關人交易

軟件許可和開發協議書

2023年10月29日，我們簽署了一封信函協議（“信函協議”）與KR8人工智能達成協議，根據該協議，KR8向我們授予了一項臨時獨家許可（“許可證”），以使用KR8的KR8人工智能生態系統和iOS/Android應用程序開發一個或多個消費者健康、健康和長壽應用程序。該信函協議限制任何此類應用程序的分發範圍僅限於北美消費者。該信函協議規定，KR8人工智能將在各方簽署最終許可協議後向我們授予具有永久期限的非臨時獨家許可。

根據信函協議，我們同意向KR8 AI支付250萬美元的初始許可和開發費，其中200萬美元將以同意的月度分期付款方式支付現金，剩餘的50萬美元將以我們的A類普通股支付，價格爲普通股在最後協議日的收盤價的102%，在紐交所美國獲得授權的前提下，（i）在KR8 AI的同意下，現金費用的部分可以以普通股的方式支付，（ii）只要普通股在主要交易所上市，自2024年7月1日起，如果平均交易量超過每天5萬美元一段時間，最多三分之一的任何月度費用可以以普通股支付。

除了許可和開發費用外，我們同意向KR8 AI支付15％的產品訂戶收入的版稅，但雙方將商定最低年度版稅。如果任何年度支付的版稅低於適用的最低限額，則許可將變爲非獨家；我們將有權通過支付不足額來保持獨家經營。

根據信函協議，KR8 人工智能將提供每月5萬美元的持續支持和維護。此外，KR8 人工智能將協助開發任何應用。我們將支付KR8 人工智能提供開發服務的全部費用的110％；前提是，首月開發服務的首款5萬美元將視爲支付了每月的維護費用。

根據信函協議，KR8 人工智能將擁有KR8 人工智能獨立執行許可協議所產生的所有知識產權，前提是根據許可協議我們將有權使用此類資產。我們將擁有所有形式的知識產權，包括我們獨自收集的樣本元數據和配對的摩貝數據，包括研究結果和生物標誌物，用於KR8 人工智能的產品，包括但不限於原始和處理後的表觀遺傳數據，提供KR8 人工智能將有權根據許可協議使用此類資產。我們和KR8 人工智能將共同擁有聯合產生的所有知識產權。

根據函件協議，雙方同意迅速進行談判並簽訂一份明確的許可協議，其中包括函件協議中所述的條款和其他習慣條款和條件，包括但不限於遞交成果物的範圍和時間、使用限制、關於保密、賠償、保險、選擇法律和論壇、違約條件、違約後的權利和救濟、保證和責任限制。如果雙方未能在2023年11月15日之前簽訂明確的許可協議，則每個方的救濟僅限於啓動仲裁，以決定所有未達成協議的問題。如果仲裁員不能就提出的每個問題提供補救措施，儘管如此，雙方仍然有義務按照函件協議履行，但可能約定終止權利。

Mark White，我們的臨時首席執行官和董事，是KR8 AI的總裁。Martin Ward，我們的臨時首席財務官，是KR8 AI的首席財務官。White先生和Ward先生均持有KR8 AI普通股5％以上的利益。

KR8 AI主許可和服務協議

2024年1月12日生效，我們與KR8 AI簽署了許可協議。我們的臨時首席執行官和臨時首席財務官各自擁有KR8 AI的股權。根據許可協議，KR8 AI授予我們有限的、不可轉讓的、永久的許可權，以使用《許可協議》附件A中列出的「許可產品」，開發、發佈和維護基於我們的表觀遺傳生物標誌技術和軟件的許可應用程序，以開發AI機器學習表觀遺傳APP以增強健康、福祉和長壽。許可協議的領土範圍僅限於美國、加拿大和墨西哥。

根據許可協議，我們同意向KR8 AI支付250萬美元的一次性許可和開發費用，以及每月5萬美元的維護費用，和根據許可協議附表中規定的條款和最低限額支付15％的「訂戶收益」的持續版稅。我們同意賠償KR8 AI在提供許可協議下的服務過程中發生的所有合理旅行和實支實付費用，除支付任何適用的小時費率。如果我們未能及時支付任何日曆年度的「最低版稅」，則該許可將變爲非獨家。

許可協議的初始期限從許可協議生效之日開始。除非按條款提前終止，否則許可協議將永久有效。如果任何一方嚴重違反本許可協議，並且這種違反行爲在非違反方書面通知違反方後30天仍未得到糾正，則任何一方均可以通過書面通知對方終止許可協議，如果非違反方提出了第二份書面通知終止許可協議，則許可協議和許可協議授予的許可將在指定的日期終止。如果有一方: (i)無力支付或未能按時支付其債務; (ii)變得無法償還債務，主動或不主動地，申請或被申請管轄，陷入任何國內或國際法院管轄下的任何破產或破產程序中; (iii)尋求以其債權人的利益爲益處而作出或尋求作出一般轉讓;(iv)申請或有被任命的接收器、受託人、保管人或類似代理人被任命，由有管轄權的法院下令管理或出售其任何實質性部分的財產或業務，則另一方可以通過書面通知終止許可協議，並立即生效，如非違約方：(i)該條件在90天通知KR8 AI的前提下，我們立即停止使用任何許可產品；(ii)因未能支付任何「初始許可費」，根據許可協議，KR8 AI可立即在提交給我們30天通知後終止許可協議。

我們可隨時在90天通知KR8 AI的條件下終止許可協議，前提是，在終止許可協議的條件下，我們立即停止使用任何許可產品。如果我們未能及時支付許可協議中應支付的任何部分的「初始許可費」，則KR8 AI可隨時在向我們發送30天通知後終止許可協議，此時許可將變爲非獨家。

根據許可協議，2024年1月19日，我們向KR8 AI發行了130萬股A類普通股。

根據授權協議，2024年10月17日，我們向KR8人工智能發行了237,037股A類普通股。

需求期限付款促銷票據

2023年9月19日，我們從公司董事安德魯·J·普爾（「安德魯」）獲得了247,233美元的貸款。2023年9月貸款用於支付董事和高管的保險費直至2023年10月。我們向普爾先生簽發了一張247,233美元的即期本票，證明了2023年9月貸款（「2023年9月票據」）。2023年9月票據2023年9月票據不設利息。2023年9月票據應貸即期償還，若無提前償還要求，將在發行日期起一年後到期。2023年9月票據可隨時部分或全部提前償還而無需支付罰金。

2023年10月2日，我們從普爾先生獲取了一筆42500美元的貸款，用於支付到2023年10月份爲止的MSK法律費用。我們向普爾先生簽發了一張42500美元的需求本票，證明了到2023年10月的貸款。2023年10月貸款）。2023年10月貸款的本金數額應按需求支付，並在沒有任何要求的情況下，自發行日起一年後到期。2023年10月的票據可能在任何時候全額或部分提前償還，而無需支付罰息。2023年10月票據）。2023年10月貸款按照逾期應計利息率13.25%計息。

Delwinds

2022年2月23日，Delwinds發行了一份金額高達$2,000,000的本票給發起人（“發起人 二月本票”）。發起人二月本票是爲了補充發起人爲Delwinds的營運費用提供的預付款。截至本代理聲明日期，發起人二月本票尚有$500,000未償還。

2022年2月24日，在業務合併相關事項中，安德魯·J·普爾（Andrew J. Poole）在簽署併購協議的同時，Delwinds的董事長兼首席執行官，以及格雷保險公司，該公司是Delwinds的某些高管和董事的關聯公司，（“後備投資者”）簽署了後備認購協議（“後備認購協議”），根據後備認購協議的條款和條件，後備投資者同意購買一定數量的新發行的A類普通股，取決於某些事件的發生，包括在業務合併完成時贖回的A類普通股數量以及其他不確定性因素。Delwinds與梅泰拉資本合作伙伴或其關聯公司簽署前置購買協議的同時，與後備投資者簽署了修訂後備認購協議（“修訂後備認購協議”），這些條款也得到Legacy FOXO的批准和同意。基於修訂後備認購協議的條款，後備投資者未根據這些協議在業務合併完成時認購Delwinds股票，因爲Delwinds與梅泰拉簽署了前置購買協議。

Delwinds已就私人定向增發單位、可轉換爲運營資本貸款的單位和可按照上述股份行權或轉換爲Delwinds A類普通股份的股份簽署了註冊和股東權利協議。

2022年9月14日，贊助商放棄了60萬股Delwinds b類普通股，並根據證券轉讓和加入協議（以下簡稱「協議」）無償將公司的所有剩餘證券分配給其成員。當期根據證券轉讓和加入協議（以下簡稱），成員成爲現有信函協議的一方，該協議已由內部人信函修訂，日期爲2020年12月10日，以及適用的登記權協議，日期爲2020年12月10日。

Legacy FOXO

自2020年1月1日以來涉及公司董事會成員或即將成爲Participant的一系列交易和類似的交易的摘要，除補償安排外，其：

公司董事和高管的補償安排在本代理聲明的其他地方有所說明。

證券的銷售和購買

可轉換債券的銷售

在2021年第一季度結束時，Legacy FOXO與2021年橋樑投資者簽署了獨立的證券購買協議和其他2021年橋樑協議，根據協議，Legacy FOXO的2021年橋樑債券的總本金爲11,812,500美元。Legacy FOXO從銷售2021年橋樑債券中獲得了淨收益961.2007美元，扣除了12.5％的原始發行折扣和887,993美元的費用和支出。2021年橋樑債券分三期發行，發行日爲2021年1月25日、2021年2月23日和2021年3月4日。2021年橋樑債券於初始發行日起十二個月到期，年利率爲12％，並要求每季度就利息支付。我們保留了爲每個發行延長到期日的權利，期限爲三個月，並承擔2021年橋樑債券未償還餘額的110％。2021年橋樑債券允許：（i）債券持有人選擇將累計本金和應計未付利息自願轉換爲每股等於OIP的A類普通股；（ii）在我們進行公開發行股票，包括特殊目的收購公司交易，總價值至少爲5,000,000美元時，強制轉換爲累計本金和應計未付利息，股票價格等於（a）每股發行價的70％或（b）OIP的較低價。2021年1月25日，Legacy FOXO還將可轉換債券發行給現任首席執行官、首席運營官以及向Legacy FOXO提供諮詢服務的顧問。其條款與2021年橋樑債券所發行的條款相同。

根據2021年橋樑修正案，Legacy FOXO和必需的2021年橋樑投資者在2022年2月22日生效，修改了某些2021年橋樑協議的條款，其中包括：（i）擴大「合格發行」的定義，以包括與特殊目的收購公司的某些交易，（ii）允許Legacy FOXO開展2022年橋樑債券的發行，（iii）允許Legacy FOXO在某些情況下將2021年橋樑債券的到期日延長5個月，（iv）在某些情況下實行對未償還本金的額外溢價。

承包商協議

2021年10月，Legacy FOXO與其前任董事之一Murdoc Khaleghi博士簽訂了承包商協議，在協議下，Khaleghi博士擔任FOXO的首席醫療官。公司支付給Khaleghi博士2022年結尾時的99000美元。此外，Khaleghi博士在根據與該公司簽訂的承包商協議相關的管理業績股權計劃下，獲得了80,000股該公司的A類普通股，該公司在2022年認可了相關的費用，金額爲29,000美元。在2022年的第四季度，Khaleghi博士和公司暫停了此項協議下的服務和付款。

賠償協議

《德拉華州公司法》第145條授權法院授予或者公司董事會授予董事和高級職員足夠廣泛的條件下授予賠償，在某些情況下，包括對根據1933年修訂版《證券法案》產生的責任進行賠償。證券法”).

公司章程規定，公司的董事、高管、員工和其他代理人，可根據DGCL的最大限度提供賠償，公司章程規定，公司的董事、高管、員工和其他代理人或DGCL允許的最大程度提供賠償。

此外，我們已與董事、高管和某些員工簽署了賠償協議，其中某些條款在某些方面比DGCL中具體的賠償條款還要廣泛。賠償協議要求公司賠償其董事因其身份或擔任董事而發生某些負債，並墊付他們因任何訴訟而導致的費用，這些訴訟可能被賠償。

諮詢協議。

2022年4月，Legacy FOXO與由Mark Peikin控制的Bespoke Growth Partners，Inc.簽訂顧問協議，在2022年6月1日修訂。諮詢師被視爲是公司的關聯方，在商業組合之前擁有超過5％的Legacy FOXO A類普通股。協議爲期12個月，在此期間，顧問將提供諮詢服務，包括但不限於，與導致Legacy FOXO上市和受到證券交易所法律條款的實現和完成有關的諮詢服務。在協議簽訂後，作爲提供服務的補償和合同期內相關費用的補償，顧問獲得了1，425美元的現金費用。諮詢協議還規定應爲服務的補償而支付股權費用。Legacy FOXO向顧問發行了1,500,000股A類普通股。這些股份旨在在商業組合完成後將轉換爲不少於80,000股的公司A類普通股。如果轉換比率的調整將顧問轉換的股份量減少至少於80,000，則顧問將獲得補償股份，以確保其在Business Combination結束後持有80,000股公司的A類普通股。這些股份最終轉換爲公司A類普通股的87,126股。

相關人員交易批准政策

董事會審查並批准與相關人員的交易。在董事會考慮與相關人員交易之前，向董事會披露相關人員在交易中的關係或利益的重要事實，除非沒有利益於交易的大多數董事批准交易，否則該交易不得獲得批准。

我們採用了一份書面的相關人交易政策，規定了如下的審查和批准或認可相關人交易的政策和程序。

「相關人交易」是指我們或我們的任何子公司參與的交易、安排或關係，涉及的金額超過12萬美元，並且其中任何相關人具有直接或間接的實質利益。 「相關人」指：

我們有旨在最小化可能與其附屬公司產生的利益衝突併爲生效期間可能存在的任何真實或潛在利益衝突提供適當程序的政策和程序。根據其章程的規定，董事會的審計委員會有責任審查相關方交易。

僱傭安排

與Merger Agreement的簽署和交付同時，我們以前的一些高管與Legacy FOXO的高管簽署了不競爭協議，該協議對Legacy FOXO和Delwinds及其各自的現有和未來的繼承人和直接和間接子公司具有約束力。根據不競爭協議，簽署者同意在Closing之後的兩年內不與Delwinds、Legacy FOXO及其各自的附屬公司競爭，並在此兩年的限制期間不招攬該實體的員工或客戶。不競爭協議還包括傳統的保密和非貶低條款。

與現任高管的協議

與我們的臨時首席執行官馬克·懷特的協議

2023年9月19日，我們與馬克·懷特（Mark White）簽署了一份臨時協議，根據協議，懷特先生同意擔任我們的臨時首席執行官和董事會成員。根據就業協議，懷特先生是一名任意解僱僱員，並將獲得1美元的年度基本工資。

懷特先生有資格參加我們的福利計劃，包括醫療、牙科和視力、400,100美元計劃、短期和長期殘疾、帶薪休假、假期和其他自願福利。我們還同意根據我們的報銷政策賠償懷特先生爲推動我們的業務而發生的合理支出。就業協議包括管理公司機密信息和工作產品的所有權。

2023年10月3日，我們根據2022年計劃向懷特先生髮行了250,000股A類普通股，以補償他爲我們提供的和將要提供的服務。這些股份不受任何業績或歸屬條件的限制，被認爲從發放日期起完全獲得，並且不受任何原因終止懷特先生與我們的僱傭關係的影響。

開啓 2024 年 7 月 25 日，我們與馬克·懷特簽訂了新的服務協議，該協議取代了臨時僱傭協議（”服務 協議”）。服務協議的初始期限至2026年7月31日。根據服務協議，懷特先生 有權獲得30,000美元的月費，懷特先生和公司均可選擇將其轉換爲股權。懷特先生 有權立即全額報銷與其擔任公司高管有關的所有費用，以及 每月補償公允市場價值不超過80,000美元的車輛的租賃和保險費用。不遲於 自服務協議簽署之日起30天后，懷特先生將發行2,000股A系列優先股。

We may terminate the Services Agreement at any time without Cause (as defined in the Services Agreement), provided that we give written notice of termination at 60 days before the date of such termination. In which case, Mr. White is be entitled to receive the following:

(i) payment of 24 months’ of monthly fees which, may be taken in cash or common stock of the Company at Mr. White’s sole option; and

(ii) reimbursement for any outstanding reasonable business expenses incurred by Mr. White in performing his duties.

We may terminate the Services Agreement at any time for Cause, provided that we give written notice of termination to Mr. White. If the Services Agreement is terminated for Cause, Mr. White is entitled to:

(i) accrued and unpaid monthly fees through the date of such termination; and

(ii) reimbursement for any outstanding reasonable business expenses incurred by Mr. White in performing his duties.

The Services Agreement will terminate upon a Change of Control (as defined in the Services Agreement). If the Services Agreement is terminated upon Change of Control, Mr. White will be entitled to:

(i) payment of 24 months of monthly fees which, may be taken in cash or common stock of the Company at Mr. White’s sole option; and

(ii) reimbursement for any outstanding reasonable business expenses incurred by Mr. White in performing his duties.

For purposes of the Services Agreement, a termination for “Change of Control” means: (i) A change in control of the Company of a nature that would be required to be reported in response to Item 6(e) of Schedule 14A of Regulation 14A as in effect on the date of this Agreement pursuant to the Exchange Act; provided that, without limitation, such a change in control will be deemed to have occurred at such time as any Acquiring Person hereafter becomes the “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of 30% or more of the combined voting power of Voting Securities; or (ii) during any period of 12 consecutive calendar months, individuals who at the beginning of such period constitute the Board of Directors cease for any reason to constitute at least a majority thereof unless the election, or the nomination for election, by the Company’s stockholders of each new director was approved by a vote of at least a majority of the directors then in office who were directors at the beginning of the period; or (iii) there will be consummated (1) any acquisition by the Company of stock or assets of another entity actively engaged in business, in connection with which the Company issues Voting Securities or any security, instrument or agreement exercisable for or convertible into Voting Securities, representing in the aggregate more than 100% of the Voting Securities outstanding prior to the entry into an agreement to consummate such acquisition, notwithstanding that the exercise or conversion of such security, instrument or agreement is subject to a vote of the shareholders of the Company, (2) any consolidation or merger of the Company in which the Company is not the continuing or surviving corporation or pursuant to which Voting Securities would be converted into cash, securities, or other property, other than a merger of the Company in which the holders of Voting Securities immediately prior to the merger have the same proportionate ownership of common stock of the surviving corporation immediately after the merger, or (3) any sale, lease, exchange, or other transfer (in one transaction or a series of related transactions) of all, or substantially all, of the assets of the Company; or (iv) approval by the stockholders of the Company of any plan or proposal for the liquidation or dissolution of the Company.

For purposes of the Services Agreement, “Acquiring Person” means any person or related person or related persons which constitute a “group” for purposes of Section 13(d) and Rule 13d-5 under the Exchange Act, as such Section and Rule are in effect as of the date of this Agreement; provided, however, that the term Acquiring Person shall not include (i) the Company or any of its subsidiaries, (ii) any employee benefit plan of the Company or any of its subsidiaries, (iii) any entity holding voting capital stock of the Company for or pursuant to the terms of any such employee benefit plan, or (iv) any person or group solely because such person or group has voting power with respect to capital stock of the Company arising from a revocable proxy or consent given in response to a public proxy or consent solicitation made pursuant to the Exchange Act.

For purposes of the Services Agreement, “Voting Securities” means the Company’s issued and outstanding securities ordinarily having the right to vote at elections for director.

Upon the termination of the Services Agreement, upon the payment of all obligations owing to Mr. White by the Company, unless the Company will otherwise request, the Consultant shall resign from all positions within the Company.

Agreement with Martin Ward, our Interim Chief Financial Officer

On September 19, 2023, we entered into an interim employment agreement with Martin Ward, pursuant to which Mr. Ward agreed to serve as our Interim Chief Financial Officer. Pursuant to the employment agreement, Mr. Ward is an at-will employee and will receive an annual base salary of $1.

Mr. Ward is eligible to participate in our benefits program, including medical, dental and vision, 401k plan, short-term and long-term disability, paid time off, holidays and other voluntary benefits. We also agreed to reimburse Mr. Ward for reasonable out-of-pocket expenses incurred in furthering our businesses, after he provides an itemized account of expenditures pursuant to our reimbursement policy. The employment agreement includes provisions governing Company confidential information and ownership of work product.

On October 3, 2023, we granted Mr. Ward 250,000 shares of Class A Common Stock pursuant to the 2022 Plan in consideration of services rendered and to be rendered to us. The shares awarded are not subject to any performance or vesting criteria, are deemed fully earned as of the grant date and are not subject to forfeiture, even if Mr. Ward’s employment with us terminates for any reason.

Myrtle Recovery Centers Acquisition

On June 10, 2024, we entered into the Stock Exchange Agreement (the “Myrtle SEA”) with Myrtle Recovery Centers, Inc., a Tennessee corporation (“Myrtle”), and Rennova Health, Inc., a Delaware corporation (“RHI”). Pursuant to the Myrtle SEA, upon closing, RHI will exchange with the Company 100 shares of Common Stock of Myrtle (which represents 98.4% of the issued and outstanding shares of Myrtle Common Stock) for total consideration of $500,000 (the “Myrtle Purchase Price”), which payment will be made by the issuance of a number of shares of Class A Common Stock of the Company determined by dividing $500,000 by the volume weighted average price (the “VWAP”) on the day immediately prior to the closing date (the “Price”) but in no event will the number of shares be more than 19.99% of the number of outstanding shares of the Company’s Class A Common Stock on the trading day prior to the closing date. If the number of FOXO Shares to be issued to RHI multiplied by the Price is less than $500,000, the Company will pay the deficit in cash within 12 months from the closing date. If the earnings before interest, taxes, depreciation and amortization (“EBITDA”) indicated in the audited financial statements of Myrtle varies by more than 10% from the Myrtle Financial Statements (as defined in the Myrtle SEA), the Myrtle Purchase Price will automatically increase or decrease on a dollar for dollar basis and, if increased, the difference will be paid in additional shares of Class A Common Stock of the Company or cash or, if decreased, the difference will result in either cancellation of Class A Common Stock of the Company or return of cash paid.

On July 17, 2024, the board of directors of the Company approved the closing of the Myrtle SEA effective as of June 14, 2024.

Mr. Lagan is an executive officer and director of RHI and Mr. Langley is a director of RHI.

Rennova Community Health Acquisition

On June 10, 2024, we entered into the Stock Exchange Agreement (the “RCHI SEA”) with Rennova Community Health, Inc., a Florida corporation (“RCHI”), and RHI.

On September 10, 2024, the Company entered into the Amended and Restated Stock Exchange Agreement with RCHI and RHI (the “Amendment”) pursuant to which the RCHI SEA was amended to change the consideration to be received by RHI in exchange for all of the equity interests of RCHI from 20,000 shares of Series A Preferred Stock of the Company to $100. In addition, under the Amendment, RCHI will issue to RHI a senior note in the principal amount of $22,000,000 (subject to adjustments) (the “Note”), which will be secured by all of the assets of RCHI and its subsidiary, Scott County Community Hospital, Inc., a Tennessee corporation (“SCCH”), under the Security and Pledge Agreement dated September 10, 2024 by, between, and among RHI, RCHI, and SCHH (the “Subsidiary Security Agreement”), with the Company and SCCH providing a guaranty on the Note pursuant to the Guaranty Agreement dated September 10, 2024 (the “Guaranty Agreement”) and with the Company providing a security interest in the “Collateral,” as defined in the Security and Pledge Agreement dated September 10, 2024 (the “Security Agreement”) with RHI.

The Note matures on September 10, 2026 and accrues interest on any outstanding principal amount at an interest rate of 8% per annum for the first six months increasing to 12% per annum after six months until maturity. After maturity, the default interest rate will be 20% per annum until the Note is paid in full. The Note requires principal repayments equal to 10% of the free cash flow (net cash from operations less capital expenditures) from RCHI and its subsidiary. Payments will be one month in arrears. The Note will be reduced by payment of 25% of any net proceeds from equity capital raised by the Company. The Note is secured by the assets of RCHI and the Company and guaranteed by Company under the Guaranty Agreement and Security Agreement, respectively.

On September 10, 2024, the board of directors of the Company approved the closing of the RCHI SEA, as amended, effective as of September 10, 2024.

Mr. Lagan is an executive officer and director of RHI and Mr. Langley is a director of RHI.

PROPOSAL 1 – AMENDMENT TO THE CERTIFICATE OF INCORPORATION TO EFFECT A REVERSE SPLIT

Overview

On [*], 2024, the Board acted unanimously to adopt the proposal for a reverse split (the “Reverse Split Proposal”) to amend Article IV of our Certificate of Incorporation to enable a potential reverse stock split of our issued and outstanding Class A Common Stock at a ratio ranging from one-for-five (1:5) to one-for-one hundred (1:100) (the “Reverse Split”) with the exact ratio within such range to be determined at the sole discretion of the Board and with such Reverse Split to be effected at such time and date, if at all, as determined by the Board in its sole discretion provided that the Reverse Split be effected prior to September 30, 2025. The Board is now asking you to approve this Reverse Split Proposal.

Effecting the Reverse Split requires that Article IV of our Certificate of Incorporation be amended to include a reference to the Reverse Split. If approved, the Reverse Split will be effective upon the filing of a Certificate of Amendment to the Certificate of Incorporation, in the form attached to this proxy statement as Appendix A, with the Secretary of State of Delaware, with such filing to occur, if at all, at the sole discretion of the Board and prior to the one-year anniversary of the date the Reverse Split is approved by our stockholders.

If implemented, except for de minimis adjustments that may result from the treatment of fractional shares as described below, the Reverse Split will not have any dilutive effect on our stockholders since each stockholder would hold the same percentage of our Class A Common Stock outstanding immediately following the Reverse Split as such stockholder held immediately prior to the Reverse Split. The relative voting and other rights that accompany the shares would not be affected by the Reverse Split.

The text of Appendix A remains subject to modification to include such changes as may be required by the Secretary of State of the State of Delaware and as our Board deems necessary or advisable to implement the Reverse Split.

Purpose and Rationale for the Reverse Split

Our Board strongly believes that the Reverse Split is necessary to maintain our listing on NYSE American.

Our Class A Common Stock is traded on the NYSE American under the symbol “FOXO”. To continue our listing on the NYSE American, we must comply with NYSE American rules. NYSE American Company Guide Section 1003(f)(v) provides that the NYSE American may delist a security when it sells for a substantial period of time at a low price per share ($0.10). Our Class A Common Stock has been trading below $1.00 for many days since October 18, 2022 through [*], 2024. On [*], 2024, the closing price was $[*]. Our Board has considered the potential harm to us and our stockholders should NYSE American delist our Class A Common Stock from NYSE American. Delisting could adversely affect the liquidity of our Class A Common Stock since alternatives, such as the OTC Markets, are generally considered to be less efficient markets. An investor would likely find it less convenient to sell, or to obtain accurate quotations in seeking to buy our Class A Common Stock on an over-the-counter market. Many investors likely would not buy or sell our Class A Common Stock due to difficulty in accessing over-the-counter markets, policies preventing them from trading in securities not listed on a national exchange or for other reasons. These policies reduce the number of potential investors in our Class A Common Stock at its current market price. Our Board believes that a Reverse Split is a potentially effective means for us to increase the per share market price of our Class A Common Stock and to avoid, or at least mitigate, the likely adverse consequences of our Class A Common Stock being delisted from the NYSE American by producing the immediate effect of increasing the bid price of our Class A Common Stock.

Management and the Board have considered the potential harm to us and our stockholders should NYSE American delist our Class A Common Stock. The Board believes that the increased market price of our Class A Common Stock expected as a result of implementing the Reverse Split could improve the marketability and liquidity of our Class A Common Stock and other securities and will encourage interest and trading in our Class A Common Stock. The Reverse Split, if effected, could allow a broader range of institutions to invest in our Class A Common Stock (namely, funds that are prohibited from buying stock whose price is below a certain threshold), potentially increasing the trading volume and liquidity of our Class A Common Stock. The Reverse Split could help increase analyst and broker interest in our Class A Common Stock, as their policies can discourage them from following or recommending companies with low stock prices. Because of the trading volatility often associated with low-priced stocks, many brokerage houses and institutional investors have internal policies and practices that either prohibit them from investing in low-priced stocks or tend to discourage individual brokers from recommending low-priced stocks to their customers. Some of those policies and practices may make the processing of trades in low-priced stocks economically unattractive to brokers. Additionally, because brokers’ commissions on low-priced stocks generally represent a higher percentage of the stock price than commissions on higher-priced stocks, a low average price per share of our Class A Common Stock can result in individual stockholders paying transaction costs representing a higher percentage of their total share value than would be the case if the share price were higher.

Our Board does not intend for this transaction to be the first step in a series of plans or proposals to effect a “going private transaction” within the meaning of Rule 13e-3 of the Exchange Act.

In addition, because the number of authorized shares of our Class A Common Stock will not be reduced, the Reverse Split will result in an effective increase in the authorized but unissued number of shares of our Class A Common Stock. The effect of the relative increase in the amount of authorized and unissued shares of our Class A Common Stock would allow us to issue additional shares of Class A Common Stock in connection with future financings, employee and director benefit programs and other desirable corporate activities, without requiring our stockholders to approve an increase in the authorized number of shares of Class A Common Stock each time such an action is contemplated, subject to applicable NYSE American rules.

We cannot assure you that the Reverse Split will have any of the desired effects described above. More specifically, we cannot assure you that after the Reverse Split the market price of our Class A Common Stock will increase proportionately to reflect the ratio for the Reverse Split, that the market price of our Class A Common Stock will not decrease to its pre-split level, that our market capitalization will be equal to the market capitalization before the Reverse Split, or that we will be able to maintain our listing on NYSE American.

Potential Disadvantages of the Reverse Split

We cannot assure you that the Reverse Split will accomplish any of the above objectives for any meaningful period of time. While we expect that the reduction in the number of outstanding shares of Class A Common Stock will increase the market price of our shares, we cannot assure you that the Reverse Split will increase the market price of our Class A Common Stock by a multiple equal to the number of pre-split shares, or result in any permanent increase in the market price of our Class A Common Stock, which is dependent upon many factors, including our business and financial performance, general market conditions and prospects for future success. If the per share market price does not increase proportionately as a result of the Reverse Split, then the value of our Company as measured by our stock capitalization will be reduced, perhaps significantly.

The number of shares held by each individual holder of Class A Common Stock would be reduced if the Reverse Split is implemented. This will increase the number of stockholders who hold less than a “round lot,” or 100 shares. Typically, the transaction costs to stockholders selling “odd lots” are higher on a per share basis. Consequently, the Reverse Split could increase the transaction costs to existing holders of Class A Common Stock in the event they wish to sell all or a portion of their position.

Although our Board believes that the decrease in the number of shares of our Class A Common Stock outstanding as a consequence of the Reverse Split and the anticipated increase in the market price of our Class A Common Stock could encourage interest in our Class A Common Stock and possibly promote greater liquidity for our stockholders, such liquidity could also be adversely affected by the reduced number of shares outstanding after the Reverse Split.

Except as set forth in this Proxy Statement, we have no specific plan, commitment, arrangement, understanding or agreement, either oral or written, regarding the issuance of Class A Common Stock subsequent to this proposed increase in the number of authorized shares at this time, and we have not allocated any specific portion of the proposed increase in the authorized number of shares to any particular purpose. However, we have in the past conducted certain public and private offerings of our securities, and we will continue to require additional capital in the near future to fund our operations. As a result, it is foreseeable that we will seek to issue such additional shares of Class A Common Stock in connection with any such capital raising activities, or any of the other activities described above. The Board does not intend to issue any Class A Common Stock or securities convertible into Class A Common Stock except on terms that the Board deems to be in the best interests of us and our stockholders.

Determination of the Ratio for the Reverse Split

In determining the split ratio to use, the Board will consider numerous factors, including the historical and projected performance of our Class A Common Stock and prevailing market conditions and general economic trends, and will place emphasis on the expected closing price of our Class A Common Stock in the period following the effectiveness of the Reverse Split. The Board will also consider the impact of the split ratios on investor interest. The purpose of selecting a range is to give the Board the flexibility to meet business needs as they arise, to take advantage of favorable opportunities and to respond to a changing corporate environment. Based on the number of shares of Class A Common Stock issued and outstanding as of [*], 2024, after completion of the Reverse Split, we will have between [*] and [*] shares of Class A Common Stock outstanding, which excludes 2,140,761 shares of Class A Common Stock held as treasury shares, depending on the “Approved Split Ratio” selected by the Board.

Principal Effects of the Reverse Split

After the effective date of the proposed Reverse Split, each stockholder will own a reduced number of shares of Class A Common Stock. Except for adjustments that may result from the treatment of fractional shares as described below, the proposed Reverse Split will affect all stockholders uniformly. The proportionate voting rights and other rights and preferences of the holders of our Class A Common Stock will not be affected by the proposed Reverse Split (other than as a result of the rounding up of fractional shares). For example, a holder of 2% of the voting power of the outstanding shares of our Class A Common Stock immediately prior to a Reverse Split would continue to hold 2% of the voting power of the outstanding shares of our Class A Common Stock immediately after such Reverse Split. The number of stockholders of record also will not be affected by the proposed Reverse Split.

The following table contains the approximate number of issued and outstanding shares of Class A Common Stock, and the estimated per share trading price following a one-for-five (1:5), one-for-fifty (1:50) and one-for-one hundred (1:100) Reverse Split, without giving effect to any adjustments for fractional shares of Class A Common Stock or the issuance of any derivative securities, as of [*], 2024.

After Each Reverse Split Ratio

After the effective date of the Reverse Split, our Class A Common Stock will have a new committee on uniform securities identification procedures (“CUSIP”) number, a number used to identify our Class A Common Stock.

Our Class A Common Stock and Public Warrants are currently registered under Section 12(b) of the Exchange Act, and we are subject to the periodic reporting and other requirements of the Exchange Act. The proposed Reverse Split will not affect the registration of our Class A Common Stock or Public Warrants under the Exchange Act. Our Class A Common Stock will continue to be reported on NYSE American under the symbol “FOXO” and the Public Warrants will be quoted on the OTC Markets under the symbol “FOXOW.”

Effect on Outstanding Derivative Securities

The Reverse Split will require that proportionate adjustments be made to the per share exercise price and the number of shares issuable upon the exercise of the Public Warrants, the Private Warrants and the Assumed Warrants, in accordance with the Approved Split Ratio.

The adjustments to these securities, as required by the Reverse Split and in accordance with the Approved Split Ratio, would result in approximately the same aggregate price being required to be paid under such securities upon exercise, and approximately the same value of shares of Class A Common Stock being delivered upon such exercise, immediately following the Reverse Split as was the case immediately preceding the Reverse Split.

Effect on Stock Option Plans

We have equity incentive plans designed primarily to provide stock-based incentives to employees pursuant to which we have issued stock options to purchase shares of the Class A Common Stock. In the event of a Reverse Split, the Board shall make appropriate adjustment to awards granted under the equity incentive plans. Accordingly, if the Reverse Split is approved by our stockholders and the Board decides to implement the Reverse Split, as of the effective date the number of all outstanding option grants, the number of shares issuable and the exercise price, as applicable, relating to options under our equity incentive plans, will be proportionately adjusted using the Approved Split Ratio. The Board has also authorized us to effect any other changes necessary, desirable or appropriate to give effect to the Reverse Split, including any applicable technical, conforming changes.

The number of shares issuable under any individual outstanding stock option shall be rounded up as permitted under the specific terms of our 2022 Plan and the 2020 Plan. Commensurately, the exercise price under each stock option would be increased proportionately such that upon exercise, the aggregate exercise price payable by the optionee to us would remain the same. Furthermore, the aggregate number of shares currently available under the 2022 Plan for future stock option and other equity-based grants will be proportionally reduced to reflect the Approved Split Ratio.

Effective Date

Upon receipt of stockholder approval for the Reverse Split Proposal, if our Board concludes that it is in the best interests of the Company and our stockholders to effect the Reverse Split by September 30, 2025, the Certificate of Amendment will be filed with the Secretary of State of the State of Delaware. The actual timing of the filing of the Certificate of Amendment with the Secretary of State of the State of Delaware to effect the Reverse Split will be determined by our Board in its sole discretion but will be no later than September 30, 2025. In addition, if for any reason our Board deems it advisable to do so, the Reverse Split may be abandoned at any time prior to the filing of the Certificate of Amendment, without further action by our stockholders. Finally, the Board alone will have sole discretion to determine the final ratio of the Reverse Split within the parameters contained in the Reverse Split Proposal. The Reverse Split will be effective as of the date of filing with the Secretary of State of the State of Delaware (the “Effective Time”).

Upon the filing of the Certificate of Amendment, without further action on our part or our stockholders, the outstanding shares of Class A Common Stock held by stockholders of record as of the Effective Time would be converted into a lesser number of shares of Class A Common Stock based on a Reverse Split ratio as determined by the Board in its sole discretion.

If the proposed Reverse Split is not approved by our stockholders, the Reverse Split will not occur.

Treatment of Fractional Shares

Our Board does not currently intend to issue fractional shares in connection with the Reverse Split. Therefore, we do not expect to issue certificates representing fractional shares. In lieu of any fractional shares, we will issue to stockholders of record who would otherwise hold a fractional share because the number of shares of Class A Common Stock they hold of record before the Reverse Split is not evenly divisible by the Reverse Split ratio that number of shares of Class A Common Stock as rounded up to the nearest whole share.

On or after the Effective Time, we will mail a letter of transmittal to each stockholder. Each stockholder will be able to obtain a certificate evidencing his, her or its post-Reverse Split shares only by sending the exchange agent (who will be the Company’s transfer agent) the stockholder’s old stock certificate(s), together with the properly executed and completed letter of transmittal and such evidence of ownership of the shares as we may require. Stockholders will not receive certificates for post-Reverse Split shares unless and until their old certificates are surrendered. Stockholders should not forward their certificates to the exchange agent until they receive the letter of transmittal, and they should only send in their certificates with the letter of transmittal. The exchange agent will send each stockholder, if elected in the letter of transmittal, a new stock certificate after receipt of that stockholder’s properly completed letter of transmittal and old stock certificate(s). A stockholder that surrenders his, her or its old stock certificate(s) but does not elect to receive a new stock certificate in the letter of transmittal will be deemed to have requested to hold that stockholder’s shares electronically in book-entry form with our transfer agent.

我們的A類普通股的一些註冊持有者以電子賬簿形式進行持有，我們的轉讓代理即我們的轉讓代理進行持有登記。這些股東沒有標明他們所持A類普通股的股票證書。但是，他們獲得了反映其帳戶中註冊股票數量的報表。如果股東以電子賬簿形式持有我們的普通股，那麼股東可以填寫並遞交適當的轉讓信。

通過代表（例如銀行或經紀人）間接持有股票的股東將被視爲持有與他們名下注冊證券相同的股份，而這些股份將進行相同的調整。但是，代理人可能有不同的流程，持有代理人名下股票的股東應該與他們的代理人聯繫。

股東在證書兌換過程中不需要支付任何服務費。

持有記錄和實益股東

截至申報日期，我們有[*]的A類普通股持有者記錄。我們預計股票分割和股份舍入將不會顯著減少記錄持有者數量。我們目前不打算在股票分割前或後尋求任何有關聯邦證券法用途的報告公司的任何更改。

如果我們的股東批准股票分割，我們的董事會決定實施股票分割，則在直接登記證券直接持有A類普通股的登記持有人記錄的股東將在交易報表中收到指示其在股票分割後持有的A類普通股的數量。持有經紀人以街名持有A類普通股的股東將得到與持有以註冊名義冠名登記證券的股東相同的處理方式，而代理人則會通知他們的受益股東進行相應的調整。然而，代理人可能具有不同的程序，持有以街名冠名登記證券的股東應該聯繫他們的代理人。

股東 不應銷燬任何拆分前的股票證書

在被要求之前，請勿提交任何證書。

反收購和股份稀釋的影響

反向拆股不會導致授權的A類普通股被稀釋。授權但未發行的A類普通股提供了董事會進行公開或私人融資、收購、股份送轉、拆股並股和授予股權激勵獎勵等各種交易的靈活性。然而，董事會可以根據其受託責任的一致和受限要求利用這些授權但未發行的股份來阻止未來企圖掌控本公司或使此類行動變得更加昂貴和不受歡迎。修正證書將繼續授予董事會授權，以在沒有股東作進一步行動的情況下，不時地發行其他股份，除非適用法律或規定要求。沒有任何計劃或建議採取其他條款或進入任何具有重大反收購影響的安排。

會計後果

反向拆股後，我們的A類普通股的每股面值將保持不變，爲0.0001美元。因此，在反向拆股的生效日期上，根據董事會選定的拆股比例，我們資產負債表上A類普通股的規定資本將按比例減少，並且未分配配股金帳戶將增加規定資本減少的金額。每股A類普通股的淨收益或損失和淨賬面價值將增加，因爲流通A類普通股的股份將減少。如果有任何，收藏的A類普通股的股份也將按比例減少，根據董事會選定的批准拆分比例。在財務報表中，所有股份的數字都會進行回溯重新編制，因此所有金額，包括每股金額，將以拆分後的基礎顯示。我們不預計反向拆股會產生任何其他會計後果。

無評估權利

根據特拉華州總公司法，我們的股東無權對本提案1行使持不同意見者權益或評估權益，如果進行股票逆向拆分，我們也不會獨立向股東提供任何此類權益。

反向拆股的某些實質性美國聯邦所得稅後果

以下討論總結了與參與反向拆分有關的某些美國聯邦所得稅後果，該參與者是以資本資產持有股票的美國股東。該討論基於1986年修訂版《內部稅收法典》的規定，以及制定的最終、臨時和擬議的美國財政部法規，以及截至本文日期有效的各項行政裁決和司法裁決。所有這些法規可能存在不同的解釋，也可能被廢除、撤銷或修改，且可能具有溯及力，這可能會實質性地改變本文所述的稅務後果。代碼

對於此摘要，"美國股東"是指對於美國聯邦所得稅目的，是以下任何一項的A類普通股的實際所有者:(1)美國公民或居民，(2)根據美國任何州或哥倫比亞特區的法律成立或組織的公司，(3)其收入不管來源都受美國聯邦所得稅管轄的受託人，或(4)如果(1)其管理受美國法院的主管和一個或多個美國人具有控制制定其所有實質性決策的權力，或(2)它根據適用的美國財政部法規有有效的選舉，以被視爲美國人。持有A類普通股的非美國持有人是指不是美國股東的股東。

This summary does not represent a detailed description of the U.S. federal income tax consequences to a stockholder in light of his, her or its particular circumstances. In addition, it does not purport to be complete and does not address all aspects of federal income taxation that may be relevant to stockholders in light of their particular circumstances or to any stockholder who may be subject to special tax rules, including, without limitation: (1) stockholders subject to the alternative minimum tax; (2) banks, insurance companies, or other financial institutions; (3) tax-exempt organizations; (4) dealers in securities or commodities; (5) regulated investment companies or real estate investment trusts; (6) traders in securities who elect to use a mark-to-market method of accounting for their securities holdings; (7) U.S. stockholders whose “functional currency” is not the U.S. dollar; (8) persons holding Class A Common Stock as a position in a hedging transaction, “straddle,” “conversion transaction” or other risk reduction transaction; (9) persons who acquire shares of Class A Common Stock in connection with employment or other performance of services; (10) dealers and other stockholders who do not own their shares of Class A Common Stock as capital assets; (11) U.S. expatriates, (12) foreign persons; (13) resident alien individuals; or (14) stockholders who directly or indirectly hold their stock in an entity that is treated as a partnership for U.S. federal tax purposes. Moreover, this description does not address the U.S. federal estate and gift tax, alternative minimum tax, or other tax consequences of the Reverse Split.

There can be no assurance that the Internal Revenue Service (the “IRS”) will not take a contrary position to the tax consequences described herein or that such position will be sustained by a court. In addition, U.S. tax laws are subject to change, possibly with retroactive effect, which may result in U.S. federal income tax considerations different from those summarized below. No opinion of counsel or ruling from the IRS has been obtained with respect to the U.S. federal income tax consequences of the Reverse Split.

This discussion is for general information only and is not tax advice. All stockholders should consult their own tax advisors with respect to the U.S. federal, state, local and non-U.S. tax consequences of the Reverse Split.

Based on the assumption that the Reverse Split will constitute a tax-free reorganization within the meaning of Section 368(a)(1)(E) of the Code, and subject to the limitations and qualifications set forth in this discussion, the following U.S. federal income tax consequences should result from the Reverse Split:

THE PRECEDING DISCUSSION IS INTENDED ONLY AS A SUMMARY OF CERTAIN FEDERAL INCOME TAX CONSEQUENCES OF A REVERSE SPLIT AND DOES NOT PURPORT TO BE A COMPLETE ANALYSIS OR DISCUSSION OF ALL POTENTIAL TAX EFFECTS RELEVANT THERETO. YOU SHOULD CONSULT YOUR OWN TAX ADVISORS AS TO THE PARTICULAR FEDERAL, STATE, LOCAL, FOREIGN AND OTHER TAX CONSEQUENCES OF A REVERSE SPLIT IN LIGHT OF YOUR SPECIFIC CIRCUMSTANCES.

REQUIRED VOTE

The affirmative vote of a majority of the shares of Class A Common Stock present and entitled to vote at the Special Meeting is required to approve this proposal. Abstentions will have the effect of a vote against this proposal.

THE BOARD RECOMMENDS A VOTE “FOR” THE APPROVAL OF THE REVERSE SPLIT.

PROPOSAL 2 – APPROVAL OF THE ISSUANCE OF SHARES IN CONNECTION WITH THE SMITHLINE EXCHANGE AGREEMENT IN ACCORDANCE WITH SECTIONS 713(A) AND 713(B) OF THE NYSE AMERICAN COMPANY GUIDE

Overview

Our Class A Common Stock is listed on NYSE American, and we are subject to Section 713(a) of the NYSE American Company Guide, which requires us to obtain stockholder approval when shares will be issued in connection with a transaction involving the sale, issuance or potential issuance by the issuer of common stock (or securities convertible into common stock) equal to 20% or more of presently outstanding shares for less than the greater of book or market value of the shares. Section 713(b) of the NYSE American Company Guide requires stockholder approval of a transaction, other than a public offering, involving the sale, issuance or potential issuance by an issuer of common stock (or securities convertible into or exercisable for common stock) when the issuance or potential issuance of additional shares may result in a change of control of the issuer.

開啓 2024 年 5 月 28 日，我們簽訂了交換協議（”史密斯林交換協議”），經9月修訂 2024 年 16 日，史密斯林根據該協議，史密斯林交換了假定認股權證，購買了調整後至多 312,500 股股票 該公司的A類普通股將於2025年2月23日終止，有權獲得公司最多13,087,514股股份 A類普通股（”權利共享”），受益所有權限制爲4.99％，發行時不設受益 任何限制性傳說。根據Smithline交易協議可能發行的供股股份總數將受到限制 至公司A類普通股已發行股份的19.99％，除非獲得股東批准發行超過A類普通股 19.99%。在執行史密斯林交易協議並收到所有供股股份後，史密斯林假定認股權證， 並且該協議下的所有相關權利都將終止。截至本文發佈之日，我們共發行了1,798,946股類別股票 根據史密斯林交易所協議發行的普通股。

因此，我們要求股東授權發行長達11,288,568股A類普通股，以滿足紐交所美國公司指南713(a)和713(b)節的股東批准要求。

背景

開啓 2022年11月18日，史密斯林對公司和公司前首席執行官喬恩·薩貝斯提起申訴 曾任公司董事會成員，紐約州最高法院，紐約縣，Index 0654430/2022。該投訴聲稱違反合同、不當致富和欺詐行爲，指控 (i) 該公司違反了合同 根據Legacy FOXO與Legacy FOXO於2021年1月25日簽訂的某些證券購買協議，其對Smithline承擔的義務 Smithline，2021年過橋債券，將於2022年2月23日到期，以及在2月之前購買FOXO普通股的假定認股權證 2024 年 23 日（統計，包括與之相關的任何修正案或其他文件，”融資文件”）， (ii) 該公司和Sabes先生因涉嫌與融資有關的作爲和不作爲而被不公正地致富 文件，以及 (iii) 公司和薩貝斯先生作了與之相關的重大虛假陳述或遺漏了重要信息 融資文件。該申訴要求就三項訴訟理由中的每項賠償至少超過6,207美元，外加律師的賠償 費用和成本。

2022年12月23日，公司將此案從紐約州紐約縣最高法院轉移至紐約州南區地方法院，案件號爲1：22-cv-10858-VEC，由法官Valerie E. Caproni審理。

2023年2月1日，被告Jon Sabes根據聯邦民事訴訟規則12（b）（2）和12（b）（6）要求駁回指控。

2023年2月22日，史密斯線提交了修改後的起訴狀。公司於2023年3月8日提交了回答修改後的起訴狀。

2023年3月15日，被告Jon Sabes根據聯邦民事訴訟規則12（b）（1），（2）和（6）要求駁回修改後的起訴狀。

2023年4月17日，史密斯線提交了對被告Sabes提出的駁回要求的反對意見。

2023年11月7日，史密斯線和公司及其子公司簽署和解協議。根據和解協議，雙方同意解決和解決它們之間的所有爭端和潛在索賠，包括在案件中提出的那些索賠，具體條款和條件詳見和解協議。在簽署和解協議，並收到全部現金和平解除權益股票後，史密斯線已終止受讓認購權證及其所代表權益及權利。

根據和解協議，公司同意支付現金解決費用，在和解協議生效日12個月紀念日之前全額支付（該日期爲「和解期限」，該期間爲「和解期間」）。在和解期間內，公司同意在任何股票融資中支付史密斯線不少於該股票融資總收益的25％，以資助現金解決費用。但是，如果公司在和解協議生效前已從Strata Purchase Agreement中獲得收益，則史密斯線將有權獲得該收益的25％作爲現金解決費用之用。

此外，公司同意盡商業上合理的努力，在2023年12月31日之前用現金向史密斯線支付30萬美元，作爲現金解決費用之一部分。如果公司未在和解期間結束之前全額支付現金解決費用，則史密斯線將有權保留根據和解協議收到的所有款項。

此外，雙方同意，在公司向史密斯線支付300,000美元的現金之前，公司不得提交任何再銷售註冊聲明以及任何附加聲明或修訂內容的文件，除了覆蓋已發行或可發行的Strata Purchase Agreement下公司A類普通股的銷售的聲明。

此外，雙方同意，在史密斯線收到公司支付的300,000美元現金之後，在和解期間內，如果公司爲除Strata Purchase Agreement以外的銷售股東提供註冊發售公司A類普通股的服務，則公司將要求發行價爲在發行前的公司A類普通股收盤價，以授權紐約證券交易所（如果公司A類普通股當時正在該交易所上交易）的方式發行解決股份，並將這些解決股份列入該註冊聲明。但是，如果將*解決股份當量較合計超過19.9％的公司A類普通股的流通總股本，則在彌合分紅並股票分拆，股票分紅併購以及其他類似交易發生後，該股份將相應減少。任何按照價格支付的解決股份的淨收益（如果有）在扣除證券經紀，轉讓代理，法律和其他與解決股份銷售相關的費用後，將用於還清現金解決費。

根據和解協議，公司同意盡最大努力獲得其Senior Pik Notes的修改，以使它們的到期日和分期償還日期延長至2024年12月31日。無論是否獲得該修改，公司均同意在現金解決費用全額支付之前不支付任何現金或股票作爲Senior Pik Notes的支付款項或將其轉換爲股票。

與和解協議的簽署同時，Smithline和Puritan Partners LLC與公司簽署了一份相互豁免協議（以下簡稱「豁免協議」）相互發布在Smithline的律師收到全額現金和解支付款項並通知後，將由第三方託管90天日曆日後才能生效。相互豁免協議包括對公司、Jon Sabes、Bespoke Growth Partners, Inc.和Mark Peikin的豁免，但前提是滿足豁免協議的條件，包括向Smithline的律師交付已簽署的解除書以解除申討方（如豁免協議中所定義）。根據相互豁免協議，如果公司申請破產並且申討方不被允許保留現金和解支付款項或者收到和解股票出售的淨收益，相互豁免協議將作廢並自始無效。此外，如果Jon Sabes、Bespoke Growth Partners, Inc.或Mark Peikin對任何回應方（如豁免協議中所定義）或申討方提起訴訟或仲裁，或以其他方式主張任何權利或訴因，或對公司還款給申討方現金和解支付款項或交付並登記和解股票有任何干擾，將使該人或實體的豁免作廢並自始無效。

根據和解協議，未經史密斯線事先書面同意，公司不得（x）在和解協議生效日後的三個月內以現金支付KR8，包括其關聯公司，款項不得超過（A）（i）從和解協議生效日到3個月內每月支付10萬美元和（ii）從和解協議生效後第4個月到第12個月內每月支付超過5萬美元擔任獎勵的15％的產品訂閱人收入，或者（y）以現金或股份向Jon Sabes支付款項，直到現金解決費全額支付。

根據和解協議，雙方同意Smithline可以保留根據《合併協議和計劃》發行給Smithline的Smithline所承擔的認股權證，並對其進行交易；但是，在Smithline全額收到現金結算款項後，該Smithline所承擔的認股權證將立即取消。此外，由於該公司在股權證到期日2024年2月23日之前沒有全額支付現金結算款項，因此Smithline所承擔的認股權證將自動延長一年至2025年2月23日，收到現金結算款項後可能會取消。從和解協議生效之日起至和解期限日，只要公司繼續遵守和解協議，Smithline就不能行使其在Smithline所承擔的認股權證下的任何權利。如果公司或其子公司受到「公司債券」（《債券條約》中定義爲）的影響，那麼在發生這種「公司債券」之前，該Smithline所承擔的認股權證將轉換爲公司及其子公司的無抵押債務，金額爲3,500,000美元，扣除公司根據和解協議向Smithline支付的現金收益或Smithline因持有任何和解股份（如有）而獲得的淨利潤。

Smithline Exchange Agreement

2024年5月28日，我們根據Smithline交易所協議進行交易，根據該協議，Smithline交換了假定的認股權證以購買最多312,500股公司的A類普通股，經調整，截止於2025年2月23日，以換取Rights Shares，受4.99%的有利所有權限制約束，並且沒有任何限制性標籤。根據Smithline交易所協議可以發行的Rights Shares總數將受限於公司已發行的A類普通股的19.99%，除非獲得股東批准發行超過19.99%的股份。一旦簽署Smithline交易所協議並收到所有Rights Shares，Smithline假定的認股權證及其所有相關權利將被終止。截至今日，我們根據Smithline交易所協議已發行了總計1,798,946股A類普通股。來自Smithline權益份額的轉售淨收益（即銷售相關費用、佣金和支出後的淨額）不得超過$2,259,747.50。在Smithline或其關聯公司（根據Smithline交易所協議定義）進行權益份額轉售後的任何周的兩個（2）交易日內，Smithline將向公司提供表明轉售的Rights Shares數量和Smithline收到的淨收益的報表。一旦總淨收益達到$2,259,747.50，Smithline交易所協議將被終止，包括任何剩餘的Rights Shares。

On September 16, 2024, we entered into Amendment No. 1 to the Smithline Exchange Agreement pursuant to which the number of Rights Shares was increased to 13,087,514.

Purpose of the Smithline Exchange Agreement

The purpose of the Smithline Exchange Agreement was to satisfy all amounts owing to Smithline and to eliminate the liability associated with the amounts owing to Smithline and the Assumed Warrant, which will help the Company to regain compliance with Section 1003(a)(i) in the NYSE American Company Guide (shareholder equity).

REQUIRED VOTE

The affirmative vote of a majority of the shares of Class A Common Stock present and entitled to vote at the Special Meeting is required to approve this proposal. Abstentions and broker non-votes with respect to this proposal will be counted for purposes of establishing a quorum. Abstentions and broker non-votes will have no effect on the outcome of the vote.

THE BOARD RECOMMENDS A VOTE “FOR” THE ISSUANCE OF SHARES IN CONNECTION WITH THE SMITHLINE EXCHANGE AGREEMENT IN ACCORDANCE WITH SECTIONS 713(A) AND 713(B) OF THE NYSE AMERICAN COMPANY GUIDE.

PROPOSAL 3 – APPROVAL OF THE ISSUANCE OF SHARES IN CONNECTION WITH THE CLEARTHINK STRATA PURCHASE AGREEMENT AND J.H. DARBIE FINDER AGREEMENT IN ACCORDANCE WITH SECTIONS 713(A) AND 713(B) OF THE NYSE AMERICAN COMPANY GUIDE

Overview

Our Class A Common Stock is listed on NYSE American, and we are subject to Section 713(a) of the NYSE American Company Guide, which requires us to obtain stockholder approval when shares will be issued in connection with a transaction involving the sale, issuance or potential issuance by the issuer of common stock (or securities convertible into common stock) equal to 20% or more of presently outstanding shares for less than the greater of book or market value of the shares. Section 713(b) of the NYSE American Company Guide requires stockholder approval of a transaction, other than a public offering, involving the sale, issuance or potential issuance by an issuer of common stock (or securities convertible into or exercisable for common stock) when the issuance or potential issuance of additional shares may result in a change of control of the issuer.

On October 13, 2023, we entered into a Strata Purchase Agreement, as supplemented by that certain Supplement to Strata Purchase Agreement, dated as of October 13, 2023 (the “Strata Supplement”) and amended on August 13, 2024, by and between us and ClearThink (as supplemented by the Strata Supplement, the “Purchase Agreement”), a Securities Purchase Agreement (the “ClearThink SPA”) and a Registration Rights Agreement (the “Registration Rights Agreement”), with ClearThink. Pursuant to the terms of the Purchase Agreement, ClearThink has agreed to purchase from us from time to time upon delivery by us to ClearThink of request notices (each a “Request Notice”), up to $5,000,000 of Class A Common Stock (subject to certain limitations) over a 24-month period, commencing upon the satisfaction of certain conditions, including that a registration statement is declared effective by the SEC.

J.H. Darbie & Co., Inc. (the “Finder”), a registered broker-dealer, acted as a finder in connection with the transactions contemplated by the Purchase Agreement and the ClearThink SPA. Pursuant to the terms of a Finder’s Fee Agreement, dated as of October 9, 2023, as amended (the “Finder Agreement”), by and between us and the Finder, we will pay the Finder cash fees equal to (i) 4% of the gross proceeds received by us from the transactions contemplated by the Purchase Agreement and (ii) Class A Common Stock representing 14% of the gross proceeds raised.

Therefore, we are asking our stockholders to authorize the issuance of up to 40,000,000 shares of our Class A Common Stock in connection with the Purchase Agreement and up to 5,600,000 shares of our Class A Common Stock in connection with the Finder Agreement in order to satisfy the stockholder approval requirements of Sections 713(a) and 713(b) of the NYSE American Company Guide.

Background

On October 13, 2023, we entered into the Purchase Agreement, the ClearThink SPA, and the Registration Rights Agreement with ClearThink. Pursuant to the terms of the Purchase Agreement, ClearThink has agreed to purchase from us from time to time upon delivery by us to ClearThink Request Notices up to $2 million of Class A Common Stock (subject to certain limitations) over a 24-month period, commencing upon the satisfaction of certain conditions, including that a registration statement is declared effective by the SEC. Pursuant to the terms of the Registration Rights Agreement, we filed with the SEC a registration statement to register for resale under the Securities Act of the shares that will or may be issued to ClearThink under the Purchase Agreement and the ClearThink SPA. The registration statement may not register all of the shares issuable pursuant to the Purchase Agreement. To sell additional shares to ClearThink under the Purchase Agreement, we may have to file one or more additional registration statements for those shares. Pursuant to the terms of the Purchase Agreement, we issued 1,000,000 shares of Class A Common Stock (the “Commitment Shares”) to ClearThink as consideration for its commitment to purchase shares of Class A Common Stock under the Purchase Agreement.

On August 13, 2024, we entered into Amendment No. 1 to the Strata Purchase Agreement pursuant to which the Commitment Amount (as defined in the Purchase Agreement) was increased from $2,000,000 to $5,000,000.

Under the Purchase Agreement, on any business day selected by us, we may direct ClearThink to purchase the lesser of $1,000,000 or 300% of the average number of shares traded for the 10 trading days prior to the closing request date, with a minimum request of $25,000. The purchase price shall be 85% of the lowest daily VWAP during a valuation period of ten trading days consisting of the five trading days preceding the purchase date with respect to a Request Notice and five trading days commencing on the first trading day following delivery and clearing of the delivered shares (in each case, to be appropriately adjusted for any reorganization, recapitalization, non-cash dividend, stock split or other similar transaction that occurs on or after the date of the Purchase Agreement). ClearThink may not assign or transfer its rights and obligations under the Purchase Agreement.

In addition, Request Notices must be at least 10 business days apart and the shares issuable pursuant to a Request Notice, when aggregated with the shares then held by ClearThink on the Request Notice date, may not exceed 4.99% of the outstanding Class A Common Stock. The Purchase Agreement further prohibits us from issuing to ClearThink any shares under the Purchase Agreement which, when aggregated with all other shares of Class A Common Stock then beneficially owned by ClearThink and its affiliates, would result in the beneficial ownership by ClearThink and its affiliates of more than 9.99% of the then issued and outstanding shares of Class A Common Stock (the “ClearThink Beneficial Ownership Limitation”).

Other than as described above, there are no trading volume requirements or restrictions under the Purchase Agreement, and we will control the timing and amount of any sales of Class A Common Stock to ClearThink.

ClearThink’s obligation to buy the shares of Class A Common Stock is subject to certain conditions being met which include the following:

Events of default under the Purchase Agreement include the following:

The “Principal Market” means the NYSE American (or any nationally recognized successor thereto); provided, however, that in the event the Class A Common Stock is ever listed or traded on The Nasdaq Global Market, The Nasdaq Global Select Market, the New York Stock Exchange, the NYSE American, the NYSE Arca, the OTC Bulletin Board, the OTCQX operated by the OTC Markets Group, Inc. or the OTCQB operated by the OTC Markets Group, Inc. (or any nationally recognized successor to any of the foregoing), then the “Principal Market” means such other market or exchange on which the Class A Common Stock is then listed or traded.

ClearThink does not have the right to terminate the Purchase Agreement upon any of the events of default set forth above, however, the Purchase Agreement will automatically terminate upon initiation of insolvency or bankruptcy proceedings by or against us. During an event of default, all of which are outside of ClearThink’s control, we may not direct ClearThink to purchase any shares of Class A Common Stock under the Purchase Agreement.

The Purchase Agreement and the ClearThink SPA prohibit us from issuing any shares of Class A Common Stock pursuant to either agreement if such issuance would cause (i) the aggregate number of shares of Class A Common Stock issued to ClearThink pursuant to such agreements to exceed 19.99% of the outstanding shares of Class A Common Stock immediately prior to the date of such agreements, unless shareholder approval pursuant to the rules and regulations of the Principal Market has been obtained or (ii) us to breach any of the rules or regulations of the Principal Market (the “Exchange Cap”).

We have the unconditional right, at any time, for any reason and without any payment or liability to us, to give notice to ClearThink to terminate the Purchase Agreement. In addition, the Purchase Agreement automatically terminates upon the bankruptcy events described above, if the satisfaction of the commencement conditions set forth in the Purchase Agreement commencement has not occurred on or before December 31, 2023 or we sell the entire $5 million of shares of Class A Common Stock.

ClearThink has agreed that neither it nor any of its affiliates shall engage in any direct or indirect short-selling or hedging of the Class A Common Stock during any time prior to the termination of the Purchase Agreement.

Pursuant to the Purchase Agreement, if within 24 months of the date of satisfaction of the commencement conditions set forth in the Purchase Agreement, we seek to enter into an equity credit line or another agreement for the sale of securities with a structure comparable to the structure in the Purchase Agreement, we will first negotiate in good faith with ClearThink as to the terms and conditions of such agreement.

All shares registered in this offering that will or may be issued or sold by us to ClearThink under the Purchase Agreement are expected to be freely tradable. Shares registered in this offering may be sold by us to ClearThink over a period of up to 24 months commencing on the date of the first registration statement became effective. The resale by ClearThink of a significant amount of shares registered in this offering at any given time, or the perception that these sales may occur, could cause the market price of the Class A Common Stock to decline and to be highly volatile. Sales of Class A Common Stock to ClearThink, if any, will depend upon market conditions and other factors to be determined by us. We may ultimately decide to sell to ClearThink all, some or none of the additional shares of Class A Common Stock that may be available for us to sell pursuant to the Purchase Agreement. If and when we do sell shares to ClearThink, after ClearThink has acquired the shares, ClearThink may resell all, some or none of those shares at any time or from time to time in its discretion. Therefore, sales to ClearThink by us under the Purchase Agreement may result in substantial dilution to the interests of other holders of Class A Common Stock. In addition, if we sell a substantial number of shares to ClearThink under the Purchase Agreement, or if investors expect that we will do so, the actual sales of shares or the mere existence of our arrangement with ClearThink may make it more difficult for us to sell equity or equity-related securities in the future at a time and at a price that we might otherwise wish to effect such sales.

However, we have the right to control the timing and amount of any additional sales of our shares to ClearThink and the Purchase Agreement may be terminated by us at any time at our discretion without any cost to us.

Pursuant to the terms of the Purchase Agreement, we have the right, but not the obligation, to direct ClearThink to purchase up to $5 million of Class A Common Stock, subject to certain limitations and exclusive of the 1,000,000 Commitment Shares to be issued to ClearThink. We have registered what could be all of the shares issuable under the Purchase Agreement; however, since the number of shares we may sell cannot be determined at this time, we may have registered only a portion of the shares issuable under the Purchase Agreement and, therefore, we may seek to issue and sell to ClearThink under the Purchase Agreement more shares of Class A Common Stock than are offered in each prospectus. If we choose to do so, we must first register for resale under the Securities Act any such additional shares, which could cause additional substantial dilution to our stockholders. The number of shares ultimately offered for resale under each prospectus is dependent upon the number of shares we direct ClearThink to purchase under the Purchase Agreement.

Pursuant to the terms of the ClearThink SPA, ClearThink agreed to purchase from us an aggregate of 2,000,000 restricted shares of Class A Common Stock for a total purchase price of $200,000 in two closings.

J.H. Darbie & Co., Inc. (the “Finder”), a registered broker-dealer, acted as a finder in connection with the transactions contemplated by the Purchase Agreement and the ClearThink SPA. Pursuant to the terms of a Finder’s Fee Agreement, dated as of October 9, 2023 (the “Finder Agreement”), as amended, by and between us and the Finder, we will pay the Finder cash fees equal to (i) 4% of the gross proceeds received by us from the transactions contemplated by the Purchase Agreement and (ii) Class A Common Stock representing 14% of the gross proceeds raised.

The term of the Finder Agreement is for 90 days (the “Term”) and both parties may terminate the Finder Agreement upon 5 days’ written notice. The Finder will be entitled to its finder’s fee if (i) during the 12 months following termination or expiration of the Finder’s Agreement, any third-party investor introduced to us by the Finder (an “Introduced Party”) purchases equity or debt securities from us or (ii) during the Term, an Introduced Party enters into an agreement to purchase securities from us which is consummated at any time thereafter. The Strata Supplement amends the Purchase Agreement by disclosing the fees to be paid by us to the Finder.

Pursuant to the terms of the Registration Rights Agreement, we agreed to file a registration statement for the resale of the shares of Class A Common Stock within 60 days of the date of the agreement.

We will pay all reasonable expenses incurred in connection with the registrations described above. However, we will not be responsible for any broker or similar concessions or any legal fees or other costs of ClearThink.

To date, we have issued shares of Class A Common Stock for gross proceeds of $456,000 in connection with the Purchase Agreement.

Factors Considered by the Board in its Recommendation

After careful consideration, our Board determined that the shares of Class A Common Stock issued under the Purchase Agreement and Finder Agreement and the transactions contemplated thereby, are advisable and in the best interests of the Company and its stockholders, and determined to recommend that our stockholders approve the proposal.

In evaluating the shares of Class A Common Stock issued under the Purchase Agreement and Finder Agreement and the transactions contemplated thereby, the Board considered a number of factors, including, but not limited to, the following material factors (not necessarily in order of relative importance):

Dilution and Impact on Existing Stockholders

The issuance of the shares of our Class A Common Stock, which are the subject of this proposal would have a dilutive effect on current stockholders in that the percentage ownership of the Company held by such current stockholders will decline as a result of the issuance. This means also that our existing stockholders will own a smaller interest in the Company as a result of such issuance and therefore have less ability to influence significant corporate decisions requiring stockholder approval. Issuance of our Class A Common Stock pursuant to this proposal could also have a dilutive effect on book value per share and any future earnings per share. Dilution of equity interests could also cause the prevailing market price for our common stock to decline.

Consequences if Stockholder Approval is Not Obtained

If we do not obtain the requisite stockholder approval of the shares of Class A Common Stock to be issued under the Purchase Agreement and Finder Agreement, additional sales of Class A Common Stock under the Purchase Agreement may not occur. Accordingly, we would not receive the gross proceeds of approximately $5 million from ClearThink as payment for the shares of our Class A Common Stock, and such funds will not be available to pursue the activities described below, substantially limiting our growth potential and we may be unable to continue as a going concern in the near term. In addition, funds raised under the Purchase Agreement will allow the Company to regain compliance with Section 1003(a)(i) in the NYSE American Company Guide (shareholder equity).

Use of Proceeds

We intend to use the net proceeds from the Purchase Agreement to support operations, working capital, and other general corporate purposes. We may find it necessary or advisable to use the net proceeds for other purposes, and management will have broad discretion in the application of the net proceeds.

Interests of Directors and Executive Officers

Our directors and executive officers have no substantial interests, directly or indirectly, in the Purchase Agreement or Finder Agreement except to the extent of their beneficial ownership of shares of our common stock.

REQUIRED VOTE

The affirmative vote of a majority of the shares of Class A Common Stock present and entitled to vote at the Special Meeting is required to approve this proposal. Abstentions, but not broker non-votes, are considered present for purposes of establishing a quorum. Abstentions and broker non-votes will have no effect on the outcome of the vote.

THE BOARD RECOMMENDS A VOTE “FOR” THE ISSUANCE OF SHARES IN CONNECTION WITH THE CLEARTHINK STRATA PURCHASE AGREEMENT AND THE J.H. DARBIE FINDER AGREEMENT IN ACCORDANCE WITH SECTIONS 713(A) AND 713(B) OF THE NYSE AMERICAN COMPANY GUIDE.

PROPOSAL 4 – APPROVAL OF THE ISSUANCE OF SHARES OF CLASS A COMMON STOCK CONNECTION WITH THE CONVERSION OF SERIES A PREFERRED STOCK ISSUED TO SENIOR NOTE HOLDERS UPON EXERCISE OF EXCHANGE PROVISIONS IN NOTES IN ACCORDANCE WITH SECTIONS 713(A) AND 713(B) OF THE NYSE AMERICAN COMPANY GUIDE

Overview

Our Class A Common Stock is listed on NYSE American, and we are subject to Section 713(a) of the NYSE American Company Guide, which requires us to obtain stockholder approval when shares will be issued in connection with a transaction involving the sale, issuance or potential issuance by the issuer of common stock (or securities convertible into common stock) equal to 20% or more of presently outstanding shares for less than the greater of book or market value of the shares. Section 713(b) of the NYSE American Company Guide requires stockholder approval of a transaction, other than a public offering, involving the sale, issuance or potential issuance by an issuer of common stock (or securities convertible into or exercisable for common stock) when the issuance or potential issuance of additional shares may result in a change of control of the issuer.

On June 12, 2024, we entered into a Securities Purchase Agreement (the “SPA”) with an institutional investor (the “Purchaser”) pursuant to which the Company agreed to issue to the Purchaser and subsequent purchasers who will also be parties to the SPA (the Purchaser, together with the purchasers, the “Purchasers”) Senior Notes in the aggregate principal amount of up to $2,800,000 (each a “Note” or, together, the “Notes”).

The closings of the SPA are as follows:

Each closing is subject to additional conditions as disclosed in the SPA. The disclosure above is not a complete description of the terms of the SPA.

On June 14, 2024 (the “Initial Closing Date”), pursuant to the SPA, the Company issued a Note in the principal amount of $840,000 to the Purchaser. The Note matures on June 14, 2025 and the principal amount of the Note is the subscription amount multiplied by 1.12 which represents 12% original issuance discount. The Note does not accrue any interest exempt for in the event of an Event of Default (as defined in the Note) upon which it will accrue interest at 18% per annum.

The Note provides the Purchaser with rights upon a Fundamental Transaction (as defined in the Note) such as assumption rights of the Successor Entity (as defined in the Note). The Note also provides the Purchaser an exchange right upon the issuance of preferred stock (except in connection with the Acquisition) and mandatory redemption rights. There is also an optional prepayment of the Note provided to the Company of 100% of the Note amount. The Note is guaranteed by RHI.

The Company issued 1,108,755 shares of Class A Common Stock to the Purchaser in connection with the first closing.

On August 1, 2024, (the “Second Closing Date”), pursuant to the SPA, the Company issued a Note in the principal amount of $280,000 to the Purchaser. The Note matures on July 31, 2025 and the principal amount of the Note is the subscription amount multiplied by 1.12 which represents 12% original issuance discount. The Note does not accrue any interest exempt for in the event of an Event of Default (as defined in the Note) upon which it will accrue interest at 18% per annum.

The Note provides the Purchaser with rights upon a Fundamental Transaction (as defined in the Note) such as assumption rights of the Successor Entity (as defined in the Note). The Note also provides the Purchaser an exchange right upon the issuance of preferred stock (except in connection with the Acquisition) and mandatory redemption rights. There is also an optional prepayment of the Note provided to the Company of 100% of the Note amount. The Note is guaranteed by RHI.

The disclosure above is not a complete description of the terms of the Notes.

Under the Note, until the Note or the Notes are no longer outstanding, in the event the Company authorizes or issues, or enters into any agreement to authorize or issue, any shares of preferred stock, the holder or holders may elect (except in the event of the issuance of shares of preferred stock of the Company, in its sole discretion, to exchange all or some of the Note or Notes then held by the holder or holders for such shares of preferred stock. With respect to any such exchange the holder or holders will receive the equivalent of $1.00 of preferred stock (or new subscription amount equivalent) for each $0.90 of principal, interest and/or liquidated damages (or any other amounts owing on the Note or Notes). By way of example, if the principal being exchanged is $750,000, then the Holder shall have the right to surrender $750,000 of principal in lieu of cash consideration in exchange for issuance of preferred stock in the amount of $825,000 (and any interest, liquidated damages or any other amounts due to the holder or holders with respect to such principal shall remain outstanding and owed to the holder or holders).

On October 16, 2024, our Board of Directors approved the designation of 35,000 shares of Series A Cumulative Convertible Redeemable Preferred Stock (the “Series A Preferred Stock”).

Each share of Preferred Stock shall have a par value of $0.0001 per share and a stated value equal to $1,000.00 (the “Stated Value”).

Assuming full funding of $2,800,000 of the Notes by the Purchaser or Purchasers (of which $1,120,000 has been funded to date), the Purchaser or Purchasers may elect to exchange up to $2,800,000 of its Notes for 3,080 shares of Series A Preferred Stock.

Each share of Series A Preferred Stock is convertible, at any time and from time to time from and after the issue date at the option of the holder, into shares of Class A Common Stock determined by dividing the Stated Value, plus any accrued and unpaid dividends thereon (whether declared or not declared), by the higher of $0.01 or 90% of the average volume-weighted average price (“VWAP”) of the five trading days immediately prior to the date the conversion notice is tendered by the holder (the “Conversion Price”). The holder may not convert in excess of 3,164,142, shares of Class A Common Stock outstanding without obtaining shareholder approval.

Therefore, we are asking our stockholders to authorize the issuance of 30,800,000 (assuming a Conversion Price of $0.10, which is the minimum closing price in order to maintain our listing on NYSE American) shares of our Class A Common Stock in connection with the conversion of shares of Series A Preferred Stock issued to the Purchaser in connection with the exercise of exchange rights in the Notes in order to satisfy the stockholder approval requirements of Sections 713(a) and 713(b) of the NYSE American Company Guide.

Factors Considered by the Board in its Recommendation

After careful consideration, our Board determined that the shares of Class A Common Stock to be issued to any Purchaser in connection with the exercise of exchange rights in the Notes, are advisable and in the best interests of the Company and its stockholders, and determined to recommend that our stockholders approve the proposal.

In evaluating the shares of Class A Common Stock to be issued, the Board considered a number of factors, including, but not limited to, the following material factors (not necessarily in order of relative importance):

Dilution and Impact on Existing Stockholders

The issuance of the shares of our Class A Common Stock, which are the subject of this proposal would have a dilutive effect on current stockholders in that the percentage ownership of the Company held by such current stockholders will decline as a result of the issuance. This means also that our existing stockholders will own a smaller interest in the Company as a result of such issuance and therefore have less ability to influence significant corporate decisions requiring stockholder approval. Issuance of our Class A Common Stock pursuant to this proposal could also have a dilutive effect on book value per share and any future earnings per share. Dilution of equity interests could also cause the prevailing market price for our common stock to decline.

Consequences if Stockholder Approval is Not Obtained

If we do not obtain the requisite stockholder approval of the shares of Class A Common Stock to be issued in connection with the conversion of shares of Series A Preferred Stock issued to any Purchaser in connection with the exercise of exchange rights in the Notes, in the event that a Purchaser exercises its exchange right in the Notes, the Company may be in default of the Notes, which are senior, and which may be have a material adverse effect on the Company’s ability to continue operations. An event of default on the Notes would trigger redemption rights for each Purchaser.

In addition, the exchange of the debt to equity and the potential to raise additional funds under the Notes may assist the Company with regaining compliance with Section 1003(a)(i) in the NYSE American Company Guide (shareholder equity).

Interests of Directors and Executive Officers

Our directors and executive officers have no substantial interests, directly or indirectly, in the Notes except to the extent of their beneficial ownership of shares of our common stock.

REQUIRED VOTE

The affirmative vote of a majority of the shares of Class A Common Stock present and entitled to vote at the Special Meeting is required to approve this proposal. Abstentions, but not broker non-votes, are considered present for purposes of establishing a quorum. Abstentions and broker non-votes will have no effect on the outcome of the vote.

THE BOARD RECOMMENDS A VOTE “FOR” THE ISSUANCE OF EITHER (1) SHARES OF CLASS A COMMON STOCK, OR (2) SHARES IN CONNECTION WITH THE CONVERSION OF SERIES A PREFERRED STOCK ISSUED TO SENIOR NOTE HOLDERS UPON EXERCISE OF EXCHANGE PROVISIONS IN NOTES IN ACCORDANCE WITH SECTIONS 713(A) AND 713(B) OF THE NYSE AMERICAN COMPANY GUIDE.

PROPOSAL 5 – APPROVAL OF ONE OR MORE ADJOURNMENTS OF THE SPECIAL MEETING TO ALATER DATE OR DATES TO SOLICIT ADDITIONAL PROXIES IF THERE ARE INSUFFICIENT VOTES TO APPROVE EACH OF THE PROPOSALS IN THIS PROXY STATEMENT

We are asking our stockholders to approve a proposal that will allow us to adjourn the Special Meeting to a later date or dates to solicit additional proxies if there are insufficient votes to approve each of the proposals in this Proxy Statement. If our stockholders approve this proposal, we could adjourn the Special Meeting and any reconvened session of the Special Meeting and use the additional time to solicit additional proxies, including the solicitation of proxies from stockholders that have previously returned properly executed proxies voting against approval of each of the proposals in this Proxy Statement. Among other things, approval of this proposal could mean that, even if we had received proxies representing a sufficient number of votes against approval of each of the proposals in this Proxy Statement, such that each proposal would be defeated, we could adjourn the Special Meeting without a vote on the approval of each of the proposals in this Proxy Statement and seek to convince the holders of those shares to change their votes to votes in favor of approval of each of the proposals in this Proxy Statement.

The Board believes that it is in the best interests of our Company and our stockholders to be able to adjourn the Special Meeting to a later date or dates if necessary or appropriate for the above-referenced reasons.

REQUIRED VOTE

The affirmative vote of a majority of the shares of Class A Common Stock present and entitled to vote at the Special Meeting is required for the approval of the adjournment proposal. Abstentions and broker non-votes with respect to this proposal will be counted for purposes of establishing a quorum. Abstentions and broker non-votes will have no effect on the outcome of the vote.

For this Proposal 5, if a quorum is not present at the Special Meeting, Article II, Subsection 2.6 of our Bylaws states that the chairman of the meeting may adjourn the Special Meeting.

THE BOARD RECOMMENDS A VOTE “FOR” THE APPROVAL OF THE ADJOURNMENT PROPOSAL.

OTHER BUSINESS

As of the date of this Proxy Statement, our management has no knowledge of any business that may be presented for consideration at the Special Meeting, other than that described above. As to other business, if any, that may properly come before the Special Meeting, or any adjournment thereof, it is intended that the proxy hereby solicited will be voted in respect of such business in accordance with the judgment of the proxy holders.

STOCKHOLDER PROPOSALS

You may present proposals for action at a future meeting or submit nominations for election of directors only if you comply with the requirements of the rules established by the SEC and our Bylaws, as applicable.

In order for a stockholder proposal to be considered for inclusion in our proxy statement and form of proxy relating to our annual meeting of stockholders to be held in 2025 pursuant to Rule 14a-8 under the Exchange Act, the proposal must be received by us via physical mail sent to our principal executive offices at 729 N. Washington Ave., Suite 600, Minneapolis, MN 55401 Attention: Management no later than [*], 2025.

Stockholders wishing to bring a proposal or nominate a director at the annual meeting to be held in 2025 under our Bylaws must provide written notice of such proposal to our Secretary at our principal executive offices between close of business [*], 2025 and close of business [*], 2025 and comply with the other provisions of our Bylaws. In addition to complying with the advance notice provisions of our Bylaws, to nominate a director, stockholders must give timely notice that complies with the additional requirements of Rule 14a-19 under the Exchange Act, which must be received no later than [*], 2025.

HOUSEHOLDING INFORMATION

Unless we have received contrary instructions, we may send a single copy of this Proxy Statement to any household at which two or more stockholders reside if we believe the stockholders are members of the same family. This process, known as “householding”, reduces the volume of duplicate information received at any one household and helps to reduce our expenses. However, if stockholders prefer to receive multiple sets of our disclosure documents at the same address this year or in future years, the stockholders should follow the instructions described below. Similarly, if an address is shared with another stockholder and together both of the stockholders would like to receive only a single set of our disclosure documents, the stockholders should follow these instructions:

WHERE YOU CAN FIND MORE INFORMATION

We file reports, proxy statements and other information with the SEC as required by the Exchange Act. You can read the Company’s SEC filings, including this Proxy Statement, over the Internet at the SEC’s website at http://www.sec.gov.

You may also obtain these documents by requesting them via e-mail from the Company at the following address and telephone number:

馬克·懷特

臨時首席執行官

729 N. Washington Ave.，Suite 600

明尼阿波利斯，MN 55401

(612) 800 0059

legal@foxotechnologies.com

如果您是公司的股東，並希望請求文件，請在2024年[*]之前的五個工作日內這樣做，以便在特別會議前收到文件。 如果您向我們請求任何文件，我們將通過第一類郵件或其他同樣迅速的方式將文件寄給您。

[*], 2024

附錄A

修正證書的形式

公司章程的修改證明書

FOXO TECHNOLOGIES INC.

富士科技有限公司，一家特拉華州公司（以下簡稱“公司”）特此證明：

第一：本公司名稱爲福克斯科技股份有限公司。

第二點： 本修改證書（以下簡稱「本修改證書」修改證明書）修訂了公司的公司章程，經修改，並對任何修改（以下簡稱“本修改租船”）進行了修訂，最後一次由提交於2023年10月23日向州務卿提交的公司章程修改證書進行了修

第三：章程新增第四條第1款，其全部內容如下：

公司有權發行的股份總數爲20,100,000,000股，包括：(i)2,000,000,000股A類普通股，每股面值爲$0.0001（"）；以及（ii）10,000,000股優先股，每股面值爲$0.0001（"）A類普通股我們對本招股說明書或任何納入本招股說明書的文件中包含的信息負有責任。本招股說明書和納入本招股說明書的文件包括我們從行業出版物和調查、以及公共申報和內部公司來源獲得的行業數據和預測的信息。行業出版物、調查和預測通常說明其中所含信息來源於認爲可靠的來源。關於我們的排名、市場地位和市場估計的聲明是基於第三方預測、管理層的估計以及我們對我們的市場和內部研究的假設。我們沒有獨立驗證這些第三方信息，也沒有確定這些來源所依賴的經濟假設基礎。雖然我們相信本招股說明書中的所有此類信息都是準確和完整的，但是這樣的數據涉及不確定性和風險，包括來自錯誤的風險，並且受到多種因素的影響，包括本招股說明書和納入本招股說明書的文件中「風險因素」和「」，的討論。和其他因素。普通股）；以及（ii）10,000,000股優先股，每股面值爲$0.0001（"）優先股”).

1. 反向股票分割。在向特拉華州國務卿提交本修正案後（”有效 時間”），在生效時間前夕已發行的每股______股A類普通股已發行股份（”舊的 普通股”）應合併並轉換爲一（1）股普通股（”新普通股”) 基於每股_____股舊普通股佔一股新普通股的比率（”反向分割率”）。 這種反向股票拆分（”反向拆分”）普通股的已發行股份不應影響總數 公司獲准發行的包括普通股在內的股本數量，應保持原樣 根據本第四條。

拆分將在公司或新普通股持有人採取任何進一步行動以及是否交回拆分前此類持有人的股票證明書的情況下進行。不得交付新普通股的任何分數股息，所有新普通股的分數股息都將四捨五入到最近的整數股數。在股票拆分中，沒有股東將獲得分數股份的現金，所有對「A類普通股」和「普通股」的引用均爲「新普通股」。

第四：改動已根據特拉華州公司法第212和242條款的規定得到批准。

第五：本修正案書將在下面寫明的日期以美國東部時間爲準生效。

公司已授權其官員簽署本次修正案書，以便在[●]，2024年簽署此證明書。